| BAXTER INTERNATIONAL INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120130676 | IN SITU TUBING MEASUREMENTS FOR INFUSION PUMPS - An infusion pump having a tubing clamping section including a movable and a stationary portion. The infusion pump includes at least one sensor for detecting a contact length of tubing within the movable and/or the stationary portion. The infusion pump includes a shuttle having a shuttle stationary and a shuttle moveable portion, and is configured to squeeze a length of the tubing between the shuttle portions. The infusion pump includes a motor connected to the shuttle moveable portion via a shaft. The motor moves the shuttle moveable portion towards and away from the shuttle stationary portion. The infusion pump includes a controller and an encoder that detects a position of the shaft. The controller converts the detected position into a travel distance of the shuttle moveable portion, and calculates a diameter and a thickness of the tubing based on the travel distance and the contact length of the tubing. | 05-24-2012 |
| 20120128653 | PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS - Described is a process for making a dry and stable hemostatic composition, said process comprising
| 05-24-2012 |
| 20120123314 | CITRATE ANTICOAGULATION SYSTEM FOR EXTRACORPOREAL BLOOD TREATMENTS - A hemofiltration system and method for pumping blood from a patient's blood stream into an access line, introducing an anticoagulant solution into the pumped blood, filtering the pumped blood and delivering it to a return line, introducing a substitution fluid into the pumped blood, introducing a calcium and magnesium solution into the blood traveling through the return line, and returning the blood back to the patient's blood stream. | 05-17-2012 |
| 20120121532 | PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS - Described is a process for making a dry and stable hemostatic composition, said process comprising | 05-17-2012 |
| 20120108513 | PURIFICATION METHOD FOR DIVALENT CATION BINDING PROTEINS ON ANION EXCHANGE RESIN - The present invention relates to a method for the purification of divalent cation binding proteins with high purity on an anion exchange resin material, to divalent cation binding proteins obtainable by said method, and to a kit comprising means for carrying out said method. | 05-03-2012 |
| 20120105850 | CASSETTE-BASED METHOD AND APPARATUS FOR MEASURING THE PRESENCE AND CONCENTRATION OF PHARMACEUTICAL SUBSTANCES IN A MEDICAL FLUID - A medical fluid delivery system includes a medical fluid delivery machine including a light source configured to generate a light beam; a polarizer configured to receive the light beam and to allow a portion of the light beam within the medical fluid to be transmitted through the polarizer, a photodetector to provide a measurement of an intensity of the light beam transmitted through a medical fluid and the polarizer; a medical fluid cassette operating with the medical fluid machine to pump the medical fluid, the medical fluid cassette loaded onto the medical fluid delivery machine such that the light source resides on a first side of the cassette and the photodetector resides on a second side of the cassette; and a computer configured to use the measurement of the intensity to determine whether the medical fluid can be delivered to a patient. | 05-03-2012 |
| 20120103902 | PERSONAL HEMODIALYSIS SYSTEM INCLUDING PRIMING SEQUENCE AND METHODS OF SAME - A dialysis machine includes a blood circuit, a dialysate circuit, and a dialyzer placed in communication with the blood circuit and the dialysate circuit. The dialysis machine includes a priming sequence in which dialysate is used to prime a first portion of the dialysate circuit and a physiologically compatible solution, other than dialysate, is used to prime a second portion of the dialysate circuit, the dialyzer and the blood circuit. | 05-03-2012 |
| 20120101422 | ELECTROMAGNETIC INDUCTION ACCESS DISCONNECT SYSTEMS - An access disconnect system includes a blood processing machine having a blood pump operable with blood tubing, first and second conductive contacts located in the blood tubing on an arterial tubing side of a blood filter. The first conductive contact is located upstream of the blood pump and the second conductive contact is located downstream of the blood pump. The first and second conductive contacts are positioned and arranged to form a conductive circuit including a vascular system of a patient and the blood processing machine. The system further includes a source of electric current connected to at least one of the first and second conductive contacts and a transmitter for sending a signal indicative of an amount of current flowing through the conductive circuit when the source of electric current is applied. | 04-26-2012 |
| 20120089085 | DIALYSIS METHODS AND SYSTEMS HAVING AUTOCONNECTION AND AUTOIDENTIFICATION - A dialysis system includes at least one pump actuator, a disposable cassette operable with the at least one pump actuator, a plurality of disposable cassette supply connections, and plurality of dialysis solution lines. Each of the plurality of solution lines is connected to a dialysis solution container. The system further includes an autoconnection mechanism configured to connect the plurality of supply connections to the plurality of dialysis solution lines. The system additionally includes an autoidentification system configured to automatically identify information associated with the plurality of dialysis solution lines to determine at least one of (i) dialysis solution type (ii) dialysis solution volume, or (iii) a number of the plurality of dialysis solution supply containers. | 04-12-2012 |
| 20120085425 | PERSONAL HEMODIALYSIS SYSTEM - A dialysis machine method includes in an embodiment applying a pneumatic closing pressure to a first valve chamber and arranging a compliance chamber to flex and absorb energy from the pneumatic closing pressure so as to tend to prevent the pneumatic closing pressure from opening an existing closure of a second valve chamber. | 04-12-2012 |
| 20120083729 | Peritoneal dialysis machine - A method for operating a dialysis cassette including a flexible membrane that covers a pump chamber includes applying a vacuum about a piston head and sucking the flexible membrane of the dialysis cassette onto the piston head; mechanically retracting the piston head along with the vacuum applied membrane away from the dialysis cassette to draw fluid into the pump chamber; mechanically extending the piston head and the flexible membrane into the pump chamber to expel fluid from the pump chamber through a flow path; and directly sensing a pressure of the fluid flowing through the flow path at a location of the dialysis cassette adjacent to the pump chamber. | 04-05-2012 |
| 20120083446 | NOVEL ALBUMIN-FREE FACTOR VIII FORMULATIONS - An albumin-free Factor VIII formulation comprising, 4% to 10% of a bulking agent selected from the group consisting of mannitol, glycine and alanine; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; 100 mM to 300 mM NaCl; and a buffering agent Alternatively, the formulation can comprise 2% to 6% hydroxyethyl starch; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; 100 mM to 300 mM NaCl; and a buffering agent. In a further embodiment, the formulation can comprise: 300 mM to 500 mM NaCl; 1% to 4% of a stabilizing agent selected from the group consisting of sucrose, trehalose, raffinose, and arginine; 1 mM to 5 mM calcium salt; and a buffering agent. | 04-05-2012 |
| 20120082987 | Transgenic Non-Human Animals Expressing Human Blood Clotting Factors and Uses Thereof - The present invention relates, in general, to development of non-human transgenic animals expressing a human blood clotting factor, such as Factor VIII, Factor VII, Factor IX and von Willebrand factor. The invention further provides methods of detecting immunogenic events against human blood clotting factor using the transgenic animals described. | 04-05-2012 |
| 20120077971 | Optimization of Nucleation and Crystallization for Lyophilization Using Gap Freezing - This application discloses devices, articles, and methods useful for producing lyophilized cakes of solutes. The devices and articles provide for a method of freezing liquid solutions of the solute by the top and the bottom of the solution simultaneously. The as frozen solution then provides a lyophilized cake of the solutes with large and uniform pores. | 03-29-2012 |
| 20120077749 | Biologically Active Peptides - A peptide or peptide derivative comprising: | 03-29-2012 |
| 20120076779 | STABILIZATION OF IMMUNOGLOBULINS AND OTHER PROTEINS THROUGH AQUEOUS FORMULATIONS WITH SODIUM CHLORIDE AT WEAK ACIDIC TO NEUTRAL ph - The present invention provides, among other aspects, storage stabile aqueous formulations of labile proteins at a mildly acidic to neutral pH. The present invention also provides methods for stabilizing a labile therapeutic protein composition at a mildly acidic to neutral pH. Advantageously, the methods and formulations provided herein allow stabile aqueous compositions of labile proteins at mildly acidic to neutral pH useful for parenteral administration. | 03-29-2012 |
| 20120076772 | STABILIZATION OF IMMUNOGLOBULINS THROUGH AQUEOUS FORMULATION WITH HISTIDINE AT WEAK ACIDIC TO NEUTRAL PH - The present invention provides, among other aspects, storage stabile aqueous formulations of immunoglobulins with histidine at a mildly acidic to neutral pH. The present invention also provides methods for stabilizing immunoglobulin compositions by formulating with histidine at a mildly acidic to neutral pH. Advantageously, the methods and formulations provided herein allow stabile aqueous compositions of immunoglobulins at mildly acidic to neutral pH useful for parenteral administration. | 03-29-2012 |
| 20120076749 | Modified Blood Factors Comprising a Low Degree of Water Soluble Polymer - The present invention relates, in general, to materials and methods for the preparation of modified blood factors which have low levels of water soluble polymer molecules conjugated to the blood factor but exhibit biological activity similar to or better than molecules having a higher number of water soluble polymer moieties. | 03-29-2012 |
| 20120071816 | AUTOMATED DIALYSIS SYSTEM INCLUDING TOUCH SCREEN CONTROLLED MECHANICALLY AND PNEUMATICALLY ACTUATED PUMPING - A peritoneal dialysis system includes: a hardware unit including a piston having a contact surface, a pneumatic source for supplying a negative pressure, a stepper motor, a controller including a processor and memory programmed to control the pneumatic source and the stepper motor, and a video monitor operating with a touch screen for sending and receiving information to and from the controller; and a disposable unit including a moveable membrane positioned adjacent to the contact surface, the programmed processor and memory operable to (i) cause the pneumatic source to apply the negative pressure to the membrane so that the negative pressure moves the membrane to conform to a shape of the contact surface and (ii) control the stepper motor so that the membrane follows the piston as the piston is moved away from the disposable unit and moves with the piston as the piston is moved into the disposable unit. | 03-22-2012 |
| 20120071815 | DRAIN AND FILL LOGIC FOR AUTOMATED PERITONEAL DIALYSIS - The present system and method in one embodiment limit a maximum instantaneous peritoneal volume to a comfortable level, while allowing the dialysis machine to advance to fill a prescribed volume whenever the drain ends after a minimum drain percentage has been attained. If a low drain condition occurs, the nominal fill volume is lowered and a therapy cycle is added, so that a prescribed total amount of fresh therapy fluid is used during therapy, maximizing therapeutic benefit. An allowable residual volume at the end of an incomplete drain is increased, thereby lowering the probability of a subsequent low drain condition. | 03-22-2012 |
| 20120071747 | USE OF VENTRICULAR ENLARGEMENT RATE IN INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF ALZHEIMERS DISEASE - The present invention relates to the use of MRI monitoring of ventricular enlargement rate as an objective measure for the purpose of assessing disease progression in patients suffering from Alzheimer's disease and for the purpose of determining therapeutic effectiveness of a treatment regimen for Alzheimer's patients. Methods for treating Alzheimer's Disease and monitoring therapeutic effectiveness are provided. | 03-22-2012 |
| 20120070498 | Submicron Particles of Antineoplastic Agents - The present invention is concerned with the formation of submicron particles of an antineoplastic agent, particularly paclitaxel, by precipitating the antineoplastic agent in an aqueous medium to form a pre-suspension followed by homogenization. Surfactants with phospholipids conjugated with a water soluble or hydrophilic polymer such as PEG are used as coating for the particles. The particles produced generally have an average particle size of less than about 1000 nm and are not rapidly soluble. | 03-22-2012 |
| 20120067805 | DIALYSIS SYSTEM METHOD HAVING SUPPLY CONTAINER AUTOCONNECTION - A dialysis system is disclosed including an autoconnection mechanism. The autoconnection mechanism in an embodiment is configured such that (i) a tip protector remover is translated in a first direction towards a plurality of supply line connectors, (ii) the tip protector remover is locked to each of a plurality of supply line tip protectors connected to the plurality of supply line connectors, (iii) the tip protector remover is translated in a second direction away from the plurality of supply line connectors to remove the plurality of supply line tip protectors from the supply line connectors, the tip protector remover is translated in a third direction different from the first and second directions, and (v) solution line connectors are translated towards the supply line connectors to connect each of the solution line connectors to one of the supply line connectors. | 03-22-2012 |
| 20120065581 | DIALYSIS SYSTEMS AND METHODS INCLUDING CASSETTE WITH AIR REMOVAL - In an embodiment, a dialysis fluid cassette is disclosed. The cassette includes a plurality of walls defining at least one valve chamber, a dialysis fluid inlet, a dialysis fluid outlet and a dialysis fluid pathway. The cassette further includes a baffle extending from a first one of the walls to an opposing second one of the walls. The baffle includes an end fixed to a third one of the plurality of walls and a free end. The fixed end separates the dialysis fluid inlet from the dialysis fluid outlet and the baffle and the plurality of walls are constructed and arranged such that the flow of dialysis fluid along the pathway defined in part by the baffle slows as the flow approaches the free end of the baffle. | 03-15-2012 |
| 20120058559 | Monocyte Activation Test Better Able to Detect Non-Endotoxin Pyrogenic Contaminants in Medical Products - An improved monocyte activation test is described that is better able to detect non-endotoxin pyrogens in medical products, in which a sample is incubated with a monocyte-containing reagent in an assay system comprising at least one surface comprising polypropylene. The invention also concerns assay systems for use in these tests that include at least one microtiter well having at least one interior surface comprising polypropylene and having a shape such that monocyte-containing reagent is concentrated in the well to provide greater cell to cell contact. The invention also relates to a diagnostic kit that can be used to test for the presence of non-endotoxin pyrogens in a sample. | 03-08-2012 |
| 20120055864 | DIALYSIS TREATMENT DEVICES FOR REMOVING UREA - Dialysis treatment devices and methods for removing urea from dialysis waste streams are provided. In a general embodiment, the present disclosure provides a dialysis treatment device including: 1) a first filter having a filtration membrane, 2) a urea removal unit having urease and in fluid communication with the first filter, and 3) a second filter having an ion rejection membrane and in fluid communication with the first filter and the urea removal unit. | 03-08-2012 |
| 20120045364 | MULTI-PART SUBSTITUTION INFUSION FLUIDS AND MATCHING ANTICOAGULANTS - A multi-part substitution infusion fluid for an extracorporeal blood treatment and methods for using same are provided. Generally, the multi-part substitution fluid comprises a first solution composed of electrolytes but without divalent cations and a second solution comprising divalent cations. Another embodiment includes a third solution comprising a matching citrate/citric acid anticoagulant. The described methods of using the multi-part substitution infusion fluids significantly reduce risks associated with various extracorporeal blood treatments. | 02-23-2012 |
| 20120043279 | SYSTEMS AND METHODS FOR PRIMING SORBENT-BASED HEMODIALYSIS - A method for priming a hemodialysis treatment includes (i) providing a sorbent cartridge for cleaning spent dialysate fluid returning from a dialyzer: (ii) preparing a batch of dialysate in a quantity commensurate with being recycled through the sorbent cartridge multiple times; (iii) priming a dialysate circuit in fluid communication with the dialyzer using the batch of dialysate; and (iv) reversing a blood pump at least one time to prime a blood circuit in fluid communication with the dialyzer using a biologically safe fluid other than dialysate. | 02-23-2012 |
| 20120041416 | DRUG DELIVERY DEVICE FOR FLUID RESTRICTED PATIENTS - A syringe assembly for connecting to an intravenous (“IV”) line includes: a syringe barrel having an actuation end and a discharge end; a syringe plunger moveable within the syringe barrel, the syringe plunger including a plunger head connected to a plunger arm; a seal between the plunger arm and the syringe barrel, the seal residing on an actuation end side of the syringe plunger; and a tube in fluid communication with the syringe barrel at a location between the seal and the plunger head, the tube having a distal end configured to be connected to the IV line. | 02-16-2012 |
| 20120040379 | METHODS FOR DIFFERENTIATING PLASMA- DERIVED PROTEIN FROM RECOMBINANT PROTEIN IN A SAMPLE - The present invention relates, in general, to methods for detecting and quantitating plasma-derived protein and recombinant protein in a sample based on the difference in protein glycosylation, when the plasma protein and the recombinant protein are essentially the same protein. | 02-16-2012 |
| 20120037558 | METHOD AND COMPOSITION FOR REMOVING UREMIC TOXINS IN DIALYSIS PROCESSES - Methods and devices for providing dialysis treatment are provided. The device includes a resin bed including zirconium phosphate, zirconium oxide, and urease. | 02-16-2012 |
| 20120037550 | HEMODIALYSIS SYSTEM WITH CASSETTE AND PINCH CLAMP - A hemodialysis system includes (i) blood tubing; (ii) a peristaltic blood pump contacting the blood tubing to pump blood through the blood tubing; (iii) a dialyzer in fluid communication with the blood tubing; (iv) first and second peristaltic dialysate pumps; (v) a dialysate heater; (vi) a plurality of pinch valves; and (vii) a cassette including a rigid structure, a heating portion, first and second dialysate pumping tubes, and a plurality of incoming tubes, the rigid structure when the cassette is mounted for operation orienting (a) the heating portion adjacent to the dialysate heater so that dialysate can be heated by the dialysate heater, (b) the first and second dialysate pumping tubes adjacent to the first and second peristaltic dialysate pumps, and (c) the plurality of incoming tubes adjacent to the plurality of pinch valves to enable the tubes to be individually closed by the pinch valves. | 02-16-2012 |
| 20120035534 | DIALYSIS SYSTEM INCLUDING WIRELESS PATIENT DATA AND TRENDING AND ALERT GENERATION - A peritoneal dialysis system includes an automated peritoneal dialysis (“APD”) machine including a logic implementer and a wireless interface receiver. The system also includes at least one of a scale or a blood pressure monitor including a wireless interface transmitter. The scale or blood pressure monitor is operable to send at least one of patient blood pressure data and patient weight data wirelessly, respectively, to the wireless interface receiver. The logic implementer is configured to store the patient blood pressure data or patient weight data. A server computer is configured to communicate with the logic implementer to receive the stored at least one patient blood pressure data and patient weight data. | 02-09-2012 |
| 20120035533 | PERITONEAL DIALYSIS MACHINE TOUCH SCREEN USER INTERFACE - A peritoneal dialysis machine including a membrane pump and a touch screen display that includes a mode-indicating portion and an operation-descriptive portion, the mode-indicating portion having a plurality of touch sensitive indicia each indicating one of a plurality of modes in which the machine can operate, the display being used to keep a patient continually informed of which one mode of at least three operating modes the machine is operating in, as the operation-descriptive portion changes to display details of a specific operation being carried out within the one mode, the indicia for each of the three operating modes always being visible to the patient while the machine is operating, the operating mode being selected by the patient touching one of the indicia on the screen. | 02-09-2012 |
| 20120035344 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE - The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a therapeutic protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime or hydrazone linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer, and wherein the conjugation is carried out in the presence of a nucleophilic catalyst. | 02-09-2012 |
| 20120035110 | METHOD OF PRODUCING RECOMBINANT HIGH MOLECULAR WEIGHT vWF IN CELL CULTURE - Among other aspects, the present invention relates to cell culture conditions for producing high molecular weight vWF, in particular, highly multimericWF with a high specific activity and ADAMTS13 with a high specific activity. The cell culture conditions of the present invention can include, for example, a cell culture medium with an increased copper concentration and/or cell culture supernatant with a low ammonium (NH | 02-09-2012 |
| 20120034674 | METHOD OF PRODUCING RECOMBINANT ADAMTS13 IN CELL CULTURE - Among other aspects, the present invention relates to cell culture conditions for producing high molecular weight vWF, in particular, highly multimericWF with a high specific activity and ADAMTS13 with a high specific activity. The cell culture conditions of the present invention can include, for example, a cell culture medium with an increased copper concentration and/or cell culture supernatant with a low ammonium (NH | 02-09-2012 |
| 20120031826 | HEMODIALYSIS SYSTEM HAVING CLAMPING MECHANISM FOR PERISTALTIC PUMPING - A hemodialysis system including (i) an instrument; (ii) first and second peristaltic dialysate pumps operated by the instrument; (iii) a cassette including a rigid structure and first and second dialysate pumping tubes carried by the rigid structure; and (iv) a mechanism configured to initially allow the cassette to be accepted by the dialysis instrument after which the mechanism engages the first and second dialysate pumping tubes for operation with the first and second peristaltic dialysate pumps. | 02-09-2012 |
| 20120029324 | THERAPY PREDICTION AND OPTIMIZATION FOR RENAL FAILURE BLOOD THERAPY, ESPECIALLY HOME HEMODIALYSIS - A method of predicting serum phosphorus concentrations in a patient during hemodialysis includes measuring serum phosphorus concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a phosphorous mobilization clearance and a pre-dialysis distribution volume of phosphorus for the patient. Serum phosphorus concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated phosphorous mobilization clearance and pre-dialysis distribution volume of phosphorus of the patient. | 02-02-2012 |
| 20120028901 | TFPI INHIBITORS AND METHODS OF USE - The invention provides peptides that bind Tissue Factor Pathway Inhibitor (TFPI), including TFPI-inhibitory peptides, and compositions thereof. The peptides may be used to inhibit a TFPI, enhance thrombin formation in a clotting factor-deficient subject, increase blood clot formation in a subject, treat a blood coagulation disorder in a subject, purify TFPI, and identify a TFPI-binding compound. | 02-02-2012 |
| 20120022442 | DIALYSIS SYSTEM AND MACHINE HAVING THERAPY PRESCRIPTION RECALL - In an embodiment, an automated peritoneal dialysis (“APD”) machine includes at least one pump, a logic implementer storing a plurality of therapy prescriptions by which to operate the at least one pump, each therapy prescription pre-approved for a particular patient, and an input device operating with the logic implementer to allow the patient to select one of the therapy prescriptions for a particular therapy. In another embodiment, the input device operating with the logic implementer allows a doctor/clinician to select or approve one of the therapy prescriptions to be run on the APD machine. In a further embodiment, the logic implementer is programmed to select or suggest one of the therapy prescriptions to be run on the APD machine. | 01-26-2012 |
| 20120022441 | MEDICAL FLUID PUMP VALVE INTEGRITY TEST METHODS AND SYSTEMS - A valve integrity method for a medical fluid pump includes pumping fluid into the medical fluid pump while an outlet valve is closed and an inlet valve is open, closing the inlet valve while the outlet valve is closed, attempting to pump fluid out of the medical fluid pump while the inlet valve and the outlet valve are closed, and determining that at least one of the valves is leaking if a change in medical fluid volume within the medical fluid pump is detected. | 01-26-2012 |
| 20120022440 | DIALYSIS SYSTEM HAVING DISPOSABLE CASSETTE - A dialysis system includes a dialysis instrument and a disposable cassette. The dialysis instrument includes three pump actuators. The disposable cassette includes three dialysate pump chambers. The three dialysate pump chambers are positioned and arranged to operate with the three dialysate pump actuators of the dialysis instrument. | 01-26-2012 |
| 20120021058 | PROCESS FOR MAKING DRY AND STABLE HEMOSTATIC COMPOSITIONS - Described is a process for making a dry and stable hemostatic composition, said process comprising
| 01-26-2012 |
| 20120020973 | CHIMERIC OSPA GENES, PROTEINS, AND METHODS OF USE THEREOF - The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of | 01-26-2012 |
| 20120018378 | RENAL FAILURE THERAPY MACHINES AND METHODS INCLUDING CONDUCTIVE AND CONVECTIVE CLEARANCE - A renal failure therapy method includes causing therapy fluid to flow to a renal failure therapy filter, directing at least twenty-five percent of the therapy fluid to the renal failure therapy filter to perform conductive clearance, and using the renal therapy failure filter to cause at least a substantial amount of the remaining therapy fluid to perform diffusive clearance. | 01-26-2012 |
| 20110319930 | DEVICE FOR MIXING AND DISPENSING OF TWO-COMPONENT REACTIVE SURGICAL SEALANT - An applicator for mixing and applying multi-component compositions to a work surface, such as two-component surgical sealants, while avoiding clogs, preventing cross-contamination of the components until a point of intended mixing at a location within the apparatus immediately upstream of an application opening in a tip cap, decreasing pressure drop along the applicator to facilitate fluid delivery, and increasing efficiency of mixing of the components. A luer hub sub-assembly having a proximal hub and a distal hub, an elongate, four-lumened cannula, and a spray tip sub-assembly are provided, with interconnections between the sub-assemblies preserving isolation of the fluid components from one another. The tip cap sub-assembly includes registration structure to assure proper alignment between tip cap and tip insert. The end wall of the tip cap includes a spinner region with three feeders leading thereto, the fluid components remaining isolated from one another in two of the feeders, and initiating mixing with one another in a third of the feeders. | 12-29-2011 |
| 20110319823 | TUBE MEASUREMENT TECHNIQUE USING LINEAR ACTUATOR AND PRESSURE SENSOR - An infusion pump uses sensors, movable members and a control unit to determine tubing thickness in a tube-loading section of the pump. The infusion pump utilizes sensors, such as a pressure sensor, to record forces imparted by a tube undergoing no pressure, a single pressure, or a pressure sweep, to determine thickness. Using these values, the tubing wall thickness can be determined. The infusion pump can also compress a tube using a movable member of the pump and records the distance traveled by the movable member to compress fully the tube. Using this distance, the tubing wall thickness can be determined. | 12-29-2011 |
| 20110315614 | DIALYSIS SYSTEM INCLUDING SUPPLEMENTAL POWER SOURCE - A dialysis system includes: a water purification unit; a dialysate generation unit configured to use water purified by the water purification unit; a dialysate delivery unit configured to deliver dialysate prepared by the dialysate generation unit; a supplemental power source; and electronic circuitry including: (i) a first electrical connection configured to electrically connect a branch power source with at least one of the water purification unit, the dialysate generation unit and the dialysate delivery unit, and (ii) a second electrical connection configured to electrically connect a supplemental power source with at least one of the water purification unit, the dialysate generation unit and the dialysate delivery unit. | 12-29-2011 |
| 20110303598 | HEMODIALYSIS SYSTEM WITH SEPARATE BLOOD CASSETTE - A hemodialysis system includes: (i) a dialyzer; (ii) a dialysate source; a dialysate pump; (iii) a dialysate cassette operatively connected to the dialysate pump such that the dialysate pump can pump dialysate through the dialysate cassette when the dialysate cassette is in fluid communication with the dialysate source, the dialysate cassette in fluid communication with the dialyzer; (iv) a blood pump; and (v) a blood cassette separate from the dialysate cassette, the blood cassette operatively connected to the blood pump such that the blood pump can pump blood through the blood cassette, the blood cassette including a housing, the housing including a from-patient tube connector, a to-patient tube connector, a saline/priming tube connector, a to-dialyzer tube connector, a from-dialyzer tube connector, and an internal air separation chamber. | 12-15-2011 |
| 20110303590 | WEIGHT/SENSOR-CONTROLLED SORBENT SYSTEM FOR HEMODIALYSIS - A hemodialysis system including (i) a dialyzer; (ii) a blood circuit including a blood pump in fluid communication with the dialyzer; (iii) a dialysate circuit including a dialysate circulation pump in fluid communication with the dialyzer, the dialysate circuit further including a sorbent cartridge for cleaning used dialysate; (iv) a container holding an initial supply of dialysate; (v) a container pump in fluid communication with the dialysate circuit and the container; (vi) a supply of concentrate; and (vii) an electronic weight balance positioned and arranged to weigh the supply of concentrate. | 12-15-2011 |
| 20110303588 | HEMODIALYSIS SYSTEM WITH HORIZONTAL CASSETTE ROLLER PUMPS - A hemodialysis system includes (i) a plurality of pump rollers: (ii) a fluid heater, the pump rollers and the heater positioned and arranged to accept a horizontally loaded dialysate cassette: (iii) a dialyzer; (iv) a sorbent cartridge; and (v) wherein the dialysate cassette includes first and second tubes for horizontal interaction with the pump rollers and a third tube for horizontal interaction with the heater, the cassette in fluid communication with the sorbent cartridge. | 12-15-2011 |
| 20110297599 | HEMODIALYSIS SYSTEM WITH MULTIPLE CASSETTE INTERFERENCE - A hemodialysis system for operation with a blood source and a dialysate source, the system including: (i) a first machine portion including a blood pump; (ii) a blood cassette operatively connected to the blood pump such that the blood pump can pump blood through the blood cassette when the blood cassette is in fluid communication with the blood source; (iii) a dialyzer fluidly connected to the blood cassette; (iv) a second machine portion separate from the first machine portion, the second machine portion including a dialysate pump; and (v) a dialysate cassette separate from the blood cassette, the dialysate cassette operatively connected to the dialysate pump such that the dialysate pump can pump dialysate through the dialysate cassette when the dialysate cassette is in fluid communication with the dialysate source, the dialysate cassette being fluidly connected to the dialyzer. | 12-08-2011 |
| 20110297598 | HEMODIALYSIS SYSTEM WITH SEPARATE DIALYSATE CASSETTE - A hemodialysis system includes (i) a dialyzer; (ii) a blood pump; (iii) a blood cassette operatively connected to the dialyzer and the blood pump; (iv) a dialysate heater; (v) first and second peristaltic dialysate pumps; and (vi) a dialysate cassette separate from the blood cassette, the dialysate cassette including an organizer configured to support a drain tube, a to-dialyzer tube and a from-dialyzer tube, the cassette further including a first pumping tube, a second pumping tube and an inline fluid heating pathway, the cassette when mounted for operation orienting (a) the first pumping tube for operation with the first peristaltic dialysate pump, (b) the second pumping tube for operation with the second peristaltic dialysate pump and (c) the fluid heating pathway for operation with the dialysate heater. | 12-08-2011 |
| 20110297593 | HEMODIALYSIS SYSTEM USING SORBENT AND RESERVOIR - A hemodialysis system including (i) a dialyzer; (ii) a blood circuit including a blood pump in fluid communication with the dialyzer; (iii) a dialysate circuit including a dialysate circulation pump in fluid communication with the dialyzer, at least a portion of the dialysate circuit incorporated into a disposable dialysate cassette; (iv) a sorbent cartridge for cleaning used dialysate flowing in the dialysate circuit; (v) a reservoir holding an initial supply of dialysate; (vi) a reservoir pump in fluid communication with the dialysate circuit and the reservoir; (vii) a supply of infusate; and (viii) an infusate pump in fluid communication with the dialysate circuit and the supply of infusate. | 12-08-2011 |
| 20110293652 | CHIMERIC OSPA GENES, PROTEINS, AND METHODS OF USE THEREOF - The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of | 12-01-2011 |
| 20110293638 | METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION WITH IMPROVED YIELD - The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein. | 12-01-2011 |
| 20110293598 | METHOD TO PRODUCE AN IMMUNOGLOBULIN PREPARATION WITH IMPROVED YIELD - The present invention provides improved methods for the manufacturing of IVIG products. These methods offer various advantages such as reduced loss of IgG during purification and improved quality of final products. In other aspects, the present invention provides aqueous and pharmaceutical compositions suitable for intravenous, subcutaneous, and/or intramuscular administration. In yet other embodiments, the present invention provides methods of treating a disease or condition comprising administration of an IgG composition provided herein. | 12-01-2011 |
| 20110293594 | REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE - The present invention provides novel methods for reducing the serine protease and/or serine protease zymogen content of a plasma-derived protein composition. Also provided are methods for manufacturing plasma-derived protein compositions having reduced serine protease and\or serine protease zymogen content. Among yet other aspects, the present invention provides aqueous and lyophilized compositions of plasma-derived proteins having reduced serine protease and/or serine protease zymogen content. Yet other aspects include methods for treating, managing, and/or preventing a disease comprising the administration of a plasma-derived protein composition having a reduced serine protease or serine protease zymogen content. | 12-01-2011 |
| 20110293443 | INFUSION PUMP WITH MULTIPLE ORIENTATION DISPLAY - An infusion pump including a pump actuator; a fluid assembly operable with the pump actuator, the fluid assembly including an outlet line; a housing configured at its front side to receive the fluid assembly and at its backside to mount in either a first orientation or a second orientation to an external support, wherein the housing supports the pump actuator and the fluid assembly in each of the orientations, and wherein the outlet line extends from a surface of the housing; a controller operably connected to the housing; and a display operably connected to the controller and supported by the front side of the housing, the display configured to be rotatable responsive so that information displayed by the display is oriented right-side-up regardless of whether the surface from which the output extends is in the first orientation or the second orientation. | 12-01-2011 |
| 20110288480 | DIALYSIS MACHINE HAVING MULTI-INPUT VOLTAGE CAPABLE HEATER - A medical fluid heating system operable with different supply voltages including first and second heater elements: first and second power lines, first, second and third switches in electrical communication with the first and second power lines, the switches configured such that (i) in a first switch state the first and second heater elements are placed in series, solely via a closing of the first switch, for operation with a first supply voltage applied to the first and second power lines, and (ii) in a second switch state the first and second heater elements are placed in parallel, via the second and third switches, for operation with a second supply voltage applied to the first and second power lines, and a control element configured to automatically set the switches in the first or the second switch state based upon a signal sent to the control element indicative of the first or the second supply voltage. | 11-24-2011 |
| 20110288464 | REGIONAL CITRATE ANTICOAGULATION - A system or method automates and optimizes citrate anticoagulant supplementation in a blood filtration circuit during CRRT. A processor-based control system interfaces with a blood filtration circuit to detect patient blood flow into the circuit, detect fluid loss through a hemofilter, and sense vital electrolyte concentrations in the blood flow, and in response, control the addition of citrate, substitution fluid, and electrolyte supplements to ensure stability of plasma concentrations in post-dilution flow returned to the patient. The controller executes the method embodied as process control algorithms for calculating an optimal citrate flow rate as a function of selected, detected, and calculated system parameters. Citrate may be added to the circuit separately, or as part of a substitution solution or a dialysate. | 11-24-2011 |
| 20110284418 | CONTAINER FOR INHALATION ANESTHETIC - A pharmaceutical product includes an inhalation anesthetic stored within an aluminum container. According to such a product, the interior of the aluminum container is provided with an inert lining comprising an epoxyphenolic resin, and the inhalation anesthetic is selected from the group consisting of sevoflurane, desflurane, isoflurane, enflurane, methoxyflurane and halothane. | 11-24-2011 |
| 20110284377 | SYSTEMS AND METHODS FOR REMOVING HYDROGEN PEROXIDE FROM WATER PURIFICATION SYSTEMS - Systems and methods for removing hydrogen peroxide from water purification systems are provided. In a general embodiment, the present disclosure provides a water purification system including a water treatment unit, an electrodeionization unit and a hydrogen peroxide decomposition catalyst in fluid connection with the electrodeionization unit. The water purification system can be fluidly connected to a renal treatment system. | 11-24-2011 |
| 20110284295 | CONTAINER SUPPORT DEVICE - A blood cleansing system includes: a weight scale; a container support device for supporting a container of a blood treating fluid, wherein the container support device includes: an attachment member for coupling the container support device to the weight scale; a joint body attached to the attachment member and configured to rotate about an axis of the attachment member; a support body secured to the joint body; and at least one container support extending from the support body, wherein the container support is configured to stably support the fluid container. | 11-24-2011 |
| 20110281938 | APTAMERS TO TISSUE FACTOR PATHWAY INHIBITOR AND THEIR USE AS BLEEDING DISORDER THERAPEUTICS - The invention relates generally to the field of nucleic acids and more particularly to aptamers that bind to TFPI, which are useful as therapeutics in and diagnostics of bleeding disorders and/or other diseases or disorders in which TFPI has been implicated. In addition, the TFPI aptamers may be used before, during and/or after medical procedures to reduce complications or side effects thereof. The invention further relates to materials and methods for the administration of aptamers that bind to TFPI. | 11-17-2011 |
| 20110275984 | CUSTOMIZABLE PERSONAL DIALYSIS DEVICE HAVING EASE OF USE AND THERAPY ENHANCEMENT FEATURES - A peritoneal dialysis machine includes an enclosure; dialysate pump located within the enclosure; a graphical user interface allowing a patient to program a treatment including at least one patient fill performed by the dialysate pump, at least one dwell, and at least one drain performed by the dialysate pump; and the GUI further programmed to provide an alert when it is time to begin the treatment so as to complete the at least one patient fill, dwell and drain by a prescribed time. | 11-10-2011 |
| 20110274758 | MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES - AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations. | 11-10-2011 |
| 20110274667 | METHODS FOR OBTAINING CELL POPULATIONS FROM ADIPOSE TISSUE - Provided herein are methods of efficiently obtaining large numbers of viable, freshly isolated cells from small amounts of adipose tissue, as well as methods of enriching or selecting for target cell populations found therein. In certain embodiments, the method of obtaining a population of cells from adipose tissue comprises incubating the adipose tissue in a solution comprising an enzyme at a concentration which is at least 200 U/ml solution and not more than about 319 U/ml solution. In some embodiments, the method is devoid of any steps which expand the population of cells obtained. In certain aspects, the method further comprises positive or negative selection steps for obtaining an enriched population of target cells from adipose tissue. Related methods of preparing a pharmaceutical composition comprising cells for administration to a patient and methods of treating a disease or medical condition in a patient are further provided herein. | 11-10-2011 |
| 20110266221 | FLOW BALANCING SYSTEM AND METHOD, ESPECIALLY FOR CITRATE - A renal failure therapy system includes a blood pump; a citrate pump; and a control unit configured to automatically control the blood pump and the citrate pump to achieve a citrate flowrate that is based on at least a blood flowrate. | 11-03-2011 |
| 20110264042 | CONDUCTIVE POLYMER MATERIALS AND APPLICATIONS THEREOF INCLUDING MONITORING AND PROVIDING EFFECTIVE THERAPY - A coupler includes a conductive polymer material that is so constructed and arranged to join tubing, wherein the conductive polymer material includes a conductive polymer component selected from the group consisting of polyaniline, polypyrrole, polythiophenes, polyethylenedioxythiophene, poly(p-phenylene vinylene) and mixtures thereof. | 10-27-2011 |
| 20110264025 | REGIONAL CITRATE ANTICOAGULATION - A system or method automates and optimizes citrate anticoagulant supplementation in a blood filtration circuit during CRRT. A processor-based control system interfaces with a blood filtration circuit to detect patient blood flow into the circuit, detect fluid loss through a hemofilter, and sense vital electrolyte concentrations in the blood flow, and in response, control the addition of citrate, substitution fluid, and electrolyte supplements to ensure stability of plasma concentrations in post-dilution flow returned to the patient. The controller executes the method embodied as process control algorithms for calculating an optimal citrate flow rate as a function of selected, detected, and calculated system parameters. Citrate may be added to the circuit separately, or as part of a substitution solution or a dialysate. | 10-27-2011 |
| 20110262555 | METHODS AND COMPOSITIONS FOR REDUCING OR PREVENTING VASCULAR CALCIFICATION DURING PERITONEAL DIALYSIS THERAPY - Methods and compositions for reducing, preventing or reducing the progression of calcification in peritoneal dialysis patients are provided. In an embodiment, the present disclosure provides a method comprising administering to a patient during peritoneal dialysis therapy a dialysis solution comprising a therapeutically effective amount of pyrophosphate ranging between about 30 μM and about 400 μM. Formulations of dialysis solutions according to the dose ranges claimed in the present disclosure allow therapeutic amounts of pyrophosphate to be delivered to peritoneal dialysis patients. | 10-27-2011 |
| 20110257891 | THERAPY PREDICTION AND OPTIMIZATION FOR RENAL FAILURE BLOOD THERAPY, ESPECIALLY HOME HEMODIALYSIS - A method of predicting serum phosphorus concentrations in a patient during hemodialysis includes measuring serum phosphorus concentrations of the patient over a hemodialysis treatment session time and an ultrafiltration rate calculated by a difference between pre- and post-dialytic body weight of the patient during an initial hemodialysis treatment session divided by a total treatment time of the treatment session and estimating a phosphorous mobilization clearance and a pre-dialysis distribution volume of phosphorus for the patient. Serum phosphorus concentrations of the patient can then be predicted at any time during any hemodialysis treatment session with the estimated phosphorous mobilization clearance and pre-dialysis distribution volume of phosphorus of the patient. | 10-20-2011 |
| 20110251574 | HEMOSTATIC SPONGE - The present invention provides a hemostatic porous composite sponge comprising
| 10-13-2011 |
| 20110251479 | USE OF VENTRICULAR ENLARGEMENT RATE IN INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF ALZHEIMER'S DISEASE - The present invention relates to the use of MRI monitoring of ventricular enlargement rate as an objective measure for the purpose of assessing disease progression in patients suffering from Alzheimer's disease and for the purpose of determining therapeutic effectiveness of a treatment regimen for Alzheimer's patients. Methods for treating Alzheimer's Disease and monitoring therapeutic effectiveness are provided. | 10-13-2011 |
| 20110238032 | MULTIPLE DRUG INFUSION SYSTEM AND METHOD - A drug infusion system includes an infusion pump; an input device; and a processor, the input device and processor configured to allow an operator to make a selection that specifies a combination of a plurality of drugs to be delivered to a patient, the input device and processor further configured to allow the operator to enter the weight of the patient, at least one of the plurality of drugs delivered based on the entered weight of the patient. | 09-29-2011 |
| 20110237998 | SYSTEMS AND METHODS FOR DIALYSIS ACCESS DISCONNECTION - An access disconnection method for a machine employing a blood circuit, the blood circuit having a machine segment and a patient access segment, the method comprising: injecting an electrical signal into the blood circuit between the machine segment and the patient access segment; attempting to cause the electrical signal to flow through only the patient access segment and to bypass the machine segment; and measuring the signal in the patient access segment and determining that an access disconnection event has occurred upon a threshold change in the measured signal. | 09-29-2011 |
| 20110236258 | MEDICAL FLUID ACCESS DEVICE WITH ANTISEPTIC INDICATOR - A medical device, such as a vascular access device, is disclosed for providing access to a medical fluid flow path for the introduction or withdrawal of medical fluids to and from the flow path. The access device includes an indicator for providing a visual indication when the access device has been exposed to an antiseptic agent. | 09-29-2011 |
| 20110230822 | MEDICAL FLUID MACHINE WITH SUPPLY AUTOCONNECTION - A medical fluid machine with supply autoconnection, the machine comprising: a cassette-receiving wall; a disposable cassette held firmly by the wall, the disposable cassette including a port spike, the port spike fitted with a spike cap; a translating shuttle including a channel sized to hold a portion of a supply tube and including a fixture for releasably holding a supply tube end; a supply tube including an end configured to be releasably held by the fixture of the channel of the translating shuttle, the supply tube fitted with a supply tube cap; a cap removal device selectively positionable between the disposable cassette and the translating shuttle; and a controller programmed to (i) translate the shuttle holding the supply tube at the supply tube end towards the disposable cassette, so that the cap removal device is likewise moved towards the disposable cassette and the spike cap of the disposable cassette is engaged, (ii) translate the shuttle holding the supply tube at the supply tube end away from the disposable cassette and the cap removal device, so that the cap removal device can pull the spike cap off of the port spike and the tube cap off of the tube end, and (iii) translate the shuttle back towards the disposable cassette to allow the port spike of the cassette to spike the tube end. | 09-22-2011 |
| 20110229455 | STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS - The present invention relates to formulations of ADAMTS13 with enhanced or desirable properties. As such, the invention provides liquid and lyophilized formulations of ADAMTS13 that are suitable for pharmaceutical administration. Among other aspects, the present invention also provides methods of treating various diseases and conditions related to VWF and/or ADAMTS13 dysfunction in a subject. Also provided herein are kits comprising ADAMTS13 formulations useful for the treatment of various diseases and conditions. | 09-22-2011 |
| 20110223231 | FRAGMENTED POLYMERIC COMPOSITIONS AND METHODS FOR THEIR USE - Cross-linked hydrogels comprise a variety of biologic and non-biologic polymers, such as proteins, polysaccharides, and synthetic polymers. Such hydrogels preferably have no free aqueous phase and may be applied to target sites in a patient's body by extruding the hydrogel through an orifice at the target site. Alternatively, the hydrogels may be mechanically disrupted and used in implantable articles, such as breast implants. When used in vivo, the compositions are useful for controlled release drug delivery, for inhibiting post-surgical spinal and other tissue adhesions, for filling tissue divots, tissue tracts, body cavities, surgical defects, and the like. | 09-15-2011 |
| 20110218487 | PUMPING MATERIAL FOR CASSETTE BASED DIALYSIS AND PUMPING MECHANISM USING SAME - A fluid pumping mechanism in one embodiment includes a fluid reservoir, and a multiple layer film extending over a portion of the fluid reservoir, wherein fluid is moved through the reservoir by movement of the film from a first position to a second position, the film including first and second layers, each of first and second layers comprising a blend of a polypropylene and a styrene ethylene butadiene block copolymer. Peritoneal dialysis systems are also provided and may include a peritoneal dialysis machine and a disposable cassette defining at least one pump chamber and having a multiple layer film extending over a portion of the at least one pump chamber, the film including first and second layers, each of the first and second layers comprising a blend of a polypropylene and a styrene ethylene butadiene block copolymer. | 09-08-2011 |
| 20110218486 | TEMPERATURE COMPENSATION FOR PNEUMATIC PUMPING SYSTEM - Temperature compensation is applied to correct for temperature mismatch between a reference chamber and a disposable chamber in a pneumatic pumping system for dialysis fluid for peritoneal dialysis. The mismatch creates an error in the calculation of pumping volume of dialysate fluid. Applying a correction for the temperature mismatch helps to more precisely control the volume of dialysate that is metered to the patient. Also disclosed are ways to keep temperatures constant and to use temperature sensors to accurately measure the temperatures of the chambers. In other aspects, the temperature of the dialysate fluid itself may be measured and used to apply a correction to the volume of fluid that is pumped to the patient. | 09-08-2011 |
| 20110217772 | ANIMAL PROTEIN FREE MEDIA FOR CULTIVATION OF CELLS - The present invention relates to animal protein free cell culture media comprising a combination of non-animal derived peptides derived from soy hydrolysate and yeast hydrolysate. The invention also provides an animal protein free culture process, wherein cells are cultivated, propagated and passaged without animal-derived components. This process is useful for cultivating cells, such as recombinant cells or cells infected with a virus, and for production biological products by cell culture processes under conditions devoid of animal protein components. | 09-08-2011 |
| 20110206655 | FVIII-INDEPENDENT FIX-MUTANT PROTEINS FOR HEMOPHILIA A TREATMENT - The present invention relates to recombinant blood coagulation factor IX (rFIX) mutants having factor VIII (FVIII) independent factor X (FX) activation potential. Five full length FIX proteins with combinations of mutations of amino acids important for functional activity of FIX and FIX wild type were cloned and expressed in HEK 293 cells. The proteins were tested by an activated partial thromboplastin time (aPTT) assay in FVIII-depleted plasma as well as in FVIII-inhibited patient plasma. In FVIII-depleted plasma functional activity of the FIX mutants was calculated as increased FVIII equivalent activity. The mutant proteins had increased FVIII equivalent activity. In FVIII-inhibited patient plasma the FEIBA equivalent activity was calculated for analysis of FVIII independent FX activation potential. The proteins had also increased FEIBA equivalent activity. Furthermore, the pre-activated FIX proteins had an increased activity in FIX-depleted plasma containing FVIII inhibitors. Therefore these FIX mutants are alternatives as bypassing agents for treatment of FVIII inhibitor patients. | 08-25-2011 |
| 20110206651 | FACTOR VIII POLYMER CONJUGATES - The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same. | 08-25-2011 |
| 20110206554 | METHODS FOR THE INACTIVATION OF MICROORGANISMS IN BIOLOGICAL FLUIDS, FLOW THROUGH REACTORS AND METHODS OF CONTROLLING THE LIGHT SUM DOSE TO EFFECTIVELY INACTIVATE MICROORGANISMS IN BATCH REACTORS - The present invention relates to a method for determining an effective dose of monochromatic or polychromatic light from one or more light sources to inactivate microorganisms present in a biological fluid, preferably a non-transparent fluid. Moreover, there is provided a method for the inactivation of microorganism in a biological fluid in a flow-through-reactor. Moreover, the invention advantageously provides a flow-through-reactor with one or more thermostated light sources. The invention further provides a method of controlling the light sum dose of monochromatic or polychromatic light emitted from one or more light sources to effectively inactivate microorganisms present in a biological fluid in a batch reactor. | 08-25-2011 |
| 20110202026 | HEMOSTATIC SPONGE - The present invention provides a hemostatic composite sponge comprising a porous matrix of a biomaterial and a material enhancing the adherence of said sponge to the applied tissue stably associated with at least one surface of said sponge, a method of producing these sponges and their use in hemostasis. | 08-18-2011 |
| 20110200577 | BIOMATRICES TO ATTRACT AND RETAIN REGENERATIVE AND REPARATIVE CELLS - The invention relates to a pharmaceutical composition which comprises a fibrin clot and a cytokine and methods of delivering the composition to a site of disease or injury in vivo to attract and retain regenerative or reparative stem or myeloid cells and their differentiated progeny. | 08-18-2011 |
| 20110196303 | FLOW PULSATILITY DAMPENING DEVICES - A medical fluid infusion system including: a fluid pathway for transporting a pulsatile flow of fluid; a dampening element in communication with the fluid pathway, the dampening element configured to actively dampen pressure fluctuations of the pulsatile flow to smoothen the pulsatile fluid flow, the dampening element operable in any orientation; and a fluid flow sensor disposed along the fluid pathway downstream of the dampening element to measure the flow rate of the smoothened fluid flow. | 08-11-2011 |
| 20110190691 | APPARATUS FOR MONITORING AND CONTROLLING PERITONEAL DIALYSIS - A dialysis apparatus includes a housing; a first electrical contact carried by the housing; a hydrogel material located within the housing; a second electrical contact connected to the hydrogel material, the hydrogel material located so as to be contacted by a liquid flowing through the housing; and wherein the hydrogel material expands as the material absorbs the liquid such that the second electrical contact is moved and eventually engage the first electrical contact. | 08-04-2011 |
| 20110190682 | NEEDLE PLACEMENT DETECTION AND SECURITY DEVICE AND METHOD - A blood access device includes (i) a conductive needle configured to pierce a patient's skin and gain access to a blood vessel; (ii) an insulative housing supporting a fluid communication junction between the needle and flexible tube; (iii) a conductor having a first end connected to the insulative housing and a second end extending from the insulative housing in a direction coextensive with the needle such that (a) when the needle has gained access to the blood vessel the patient's skin, the conductor is electrically insulated from the conductive needle and (b) if the needle is pulled so as to interrupt access with the blood vessel, the conductive needle and the conductor come into contact with each other. | 08-04-2011 |
| 20110190681 | CATHETER NEEDLE RETENTION AND PLACEMENT MONITORING SYSTEM AND METHOD - A blood access device includes (i) a first layer, a bottom surface of the first layer including (a) an adhesive or (b) a hook and loop material for securing the first layer to a patient, a first conductive attachment material located at a top surface of the first layer; (ii) a first conductor contacting the first conductive attachment material; (iii) a second layer, a second conductive attachment material located at a bottom surface of the second layer, the first and second conductive attachment materials configured to be releasably secured to each other; (iv) a second conductor contacting the second conductive attachment material; and (v) a blood vessel access member carried by the second layer. | 08-04-2011 |
| 20110177094 | IVIG MODULATION OF CHEMOKINES FOR TREATMENT OF MULTIPLE SCLEROSIS, ALZHEIMER'S DISEASE, AND PARKINSON'S DISEASE - The present invention provides methods for providing a prognosis of treatment of diseases associated with inflammatory disease of the brain, including MS, e.g., relapsing-remitting multiple sclerosis (RRMS), Alzheimer's disease, and Parkinson's disease using molecular markers that are shown to be overexpressed or underexpressed in patients treated with intravenous immunoglobulins (IVIG). Also provided are methods to identify compounds that are useful for the treatment or prevention of MS, e.g., relapsing-remitting multiple sclerosis (RRMS), Alzheimer's disease, and Parkinson's disease. | 07-21-2011 |
| 20110172703 | TISSUE SEALANT APPLICATOR SYSTEM - A tissue sealant applicator system includes a tissue sealant applicator having an elongate body forming a bore containing a tissue sealant component, a piston, and a spray adaptor in fluid communication with the bore and forming a gas flow path. The system also includes a control unit adapted to be connected to a gas source, and a first gas passageway connecting the gas flow path and the control unit. The applicator includes an actuating member cooperatively associated with the piston to eject the tissue sealant from the bore upon user actuation. The control unit is adapted to supply gas from the gas source to the first gas passageway essentially simultaneously with user actuation of the actuating member, and to permit the supply of gas to the spray adaptor from the gas source to continue to flow for a predetermined time delay after the user stops actuating the actuating member. | 07-14-2011 |
| 20110172592 | MEMBRANE PORT COMPATIBLE WITH STEAM STERILIZATION - A medical connector comprising a body having a first end, a second end and a body wall defining an interior. A removable cap is fixed to the first end to seal the first end, the cap having a first filter. A filter plug having a proximal end, a distal end, a second filter and defining a spike path on an interior of the filter plug fluidly seals to an inside surface of the body wall. The distal end of the filter plug also has a removable membrane that blocks the spike path. The medical connector also provides a steam path with at least a portion of which is provided between the body wall and the filter plug. The medical connector can also comprise a first port and second port connected together to define the connector interior. The medical connector can provide the first filter on the connector body. | 07-14-2011 |
| 20110171087 | Pipette System, Pipette Tip Assembly and Kit - A pipette tip assembly includes a pipette tip having a first open end adapted to receive a pipette tip mounting shaft of a pipette, a second open end, and an open channel therebetween. The assembly also includes a mixer disposed in the channel, the mixer including at least one porous mixing device. The at least one porous mixing device includes a three-dimensional lattice defining a plurality of tortuous, interconnecting passages therethrough, and has physical characteristics to sufficiently mix first and second fluids drawn or expelled through the mixer, which characteristics include a selected one or more of mean flow pore size, thickness and porosity. | 07-14-2011 |
| 20110169834 | METHODS AND APPARATUS FOR DISPLAYING FLOW RATE GRAPHS AND ALARMS ON A DIALYSIS SYSTEM - The present disclosure provides methods and apparatus for displaying flow rate graphs and alarms on a dialysis system. The disclosed methods and apparatus allow a user to simultaneously view a normal flow rate graph, one or more abnormal flow rate graphs, an actual flow rate graph, and an alarm type. Preferably, the three graphs are at the same scale and time-aligned so the user can quickly diagnose issues associated with drain and catheter problems. | 07-14-2011 |
| 20110166596 | Mixing System, Kit and Mixer Adapter - A system includes a cylinder having a bore with a piston disposed therein, the piston moveable along the bore of the cylinder and having a passage therethrough. The system also includes a mixer disposed in the passage in the piston and including at least one porous mixing device, the at least one porous mixing device comprising a three-dimensional lattice defining a plurality of tortuous, interconnecting passages therethrough, and having physical characteristics to sufficiently mix the first and second components, which characteristics include a selected one or more of mean flow pore size, thickness and porosity. | 07-07-2011 |
| 20110166507 | DIALYSIS SYSTEMS AND METHODS HAVING DISPOSABLE CASSETTE AND INTERFACE THEREFORE - A medical fluid flow control system comprises an interface including a pump actuator port and a pump seal port, a membrane gasket including a pump actuation area and a pump aperture, and a pumping cassette including a flexible sheet and defining a pump chamber, a pump portion of the flexible sheet covering the pump chamber. The pump seal port is operable with the pump aperture to seal the pump portion of the flexible sheet to the pump actuation area of the membrane gasket and the pump actuator port is configured to move the pump portion of the flexible sheet and the pump actuation area of the membrane gasket at the pump chamber of the cassette. | 07-07-2011 |
| 20110163033 | NOISE-REDUCING DIALYSIS SYSTEMS AND METHODS OF REDUCING NOISE IN DIALYSIS SYSTEMS - A dialysis system includes at least one pneumatic valve, a pneumatic pump in fluid communication with the pneumatic valve, a pneumatic line communicating with an inlet and an outlet of the pneumatic pump, a flow restrictor placed in the pneumatic line, and a logic implementer. The logic implementer is programmed to operate the pneumatic valve to either (i) communicate the pneumatic outlet with the pneumatic inlet of the pneumatic pump through the flow restrictor and the pneumatic line, or (ii) communicate the outlet of the pneumatic pump with a component of the dialysis system. | 07-07-2011 |
| 20110160653 | INFUSION PUMP INCLUDING PAIN CONTROLLED ANALGESIC ("PCA") APPARATUS - An infusion pump includes: a housing, a pump actuator supported by the housing, electronics configured to control the pump actuator, a pain controlled analgesic (“PCA”) input device, a cord having a remote end connected to the PCA input device and a local end connected to the housing, a remote integrated circuit; and a local integrated circuit in communication with the electronics and the remote integrated circuit so as to provide operational information concerning the PCA input device to the electronics. | 06-30-2011 |
| 20110159031 | Vaccine to Influenza A Virus - The present invention relates, in general, to compositions and methods for administering a vaccine against influenza to a subject, the vaccine comprising a vaccinia virus vector and a hemagglutinin and neuraminidase gene, separate or in combination, from an influenza A virus. | 06-30-2011 |
| 20110158823 | SHUTTLE PUMP WITH CONTROLLED GEOMETRY - An infusion pump uses an improved shuttle mechanism to more reliably pump liquids in low volumes for medical and other purposes. The improved shuttle uses linear translation and wider, symmetric jaws to grasp infusate tubing and pump liquid infusate through the tubing. Adjustment of the linear motion allows a user to also adjust a pumping volume of the infusion pump. Other shuttles with wider jaws may also pump infusate using a rotary motion. In addition, more than one shuttle, such as two or three shuttles, may be used to approximate continuous pumping. A series of several smaller linear shuttles with sequential actuation may be used as a linear peristaltic pump for general peristaltic pump applications. | 06-30-2011 |
| 20110155620 | RAPID RECONSTITUTION FOR LYOPHILIZED-PHARMACEUTICAL SUSPENSIONS - A method of preparing and reconstituting a sterile, lyophilized pharmaceutical active for rapid reconstitution by evacuating a lyophilized pharmaceutical active-containing container until the pressure within the container is less than about 300 Torr and hermetically sealing the evacuated container. The sterile, lyophilized pharmaceutical active can be prepared by flash freezing a pharmaceutical active-containing composition then lyophilizing the composition. The hermetically sealed lyophilized pharmaceutical active can be reconstituted by adding at least the total volume of liquid necessary for reconstitution of the sterile, lyophilized pharmaceutical active to the sterile, lyophilized pharmaceutical active, sealed under a pressure of less than about 300 Torr, in less than about 10 seconds to yield, within about 5 minutes, an administrable pharmaceutical active-containing composition. One aspect of the herein described sterile, lyophilized pharmaceutical active is a packaged sterile pharmaceutical active comprising an evacuated, hermetically sealed container having disposed therein a sterile, lyophilized pharmaceutical active, sealed under a pressure of less than about 300 Torr. | 06-30-2011 |
| 20110154682 | Device and Method for Automatically Opening and Closing a Material Container During a Lyophilization Process - A device for storing a material to be lyophilized includes a support panel, a sidewall, an opening, a cover, and at least one lifter device. The sidewall and the support panel define a storage space for accommodating a material. The opening is defined by a rim of the sidewall. The cover is removably disposed adjacent to the rim of the sidewall for closing the opening. The lifter device is disposed between the support panel and the cover and includes a reservoir and at least one movable wall. The reservoir defines a sealed cavity containing a fluid. The movable wall is in operable communication with the fluid in the sealed cavity and engaging the cover to displace the cover away from the rim when the lifter device is subject to an ambient pressure that is less than the pressure of the fluid in the sealed cavity. | 06-30-2011 |
| 20110154681 | THERMAL SHIELDING TO OPTIMIZE LYOPHILIZATION PROCESS FOR PRE-FILLED SYRINGES OR VIALS - A device for supporting at least one vessel containing a target material to be lyophilized generally includes a support panel, a central region, a perimeter region, a thermal shield, and at least one shielding cavity. The support panel has a support surface. The central region is defined by the support panel for supporting the at least one vessel. The perimeter region is also defined by the support panel and surrounding the central region. The thermal shield is positioned about the perimeter region and extends transverse to the support surface of the support panel such that the thermal shield and the support panel define a storage space for accommodating the at least one vessel. The at least one shielding cavity is defined by the thermal shield and contains a shielding material during a lyophilization process. The shielding material is distinct from the target material. | 06-30-2011 |
| 20110154520 | Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives - The invention relates to a novel polypeptide vitamin K epoxide recycling polypeptide (VKORC1) as a target for coumarin and its derivatives. The invention further provides methods for identifying coumarin derivatives, and also claims VKORC1 polypeptides and VKORC1 nucleic acids containing a sequence abnormality associated with a VKORC1 associated deficiency such as warfarin resistance, wherein the VKORC1 polypeptides and VKORC1 nucleic acids can be used for diagnosing these deficiencies. Moreover, the invention relates to methods for identifying coumarin derivatives usable in pest control of rodents. | 06-23-2011 |
| 20110151512 | OLIGOPEPTIDE-FREE CELL CULTURE MEDIA - The present invention relates to oligopeptide-free cell culture media comprising at least 0.5 mg/L of a polyamine and to methods for cultivating cells in said oligopeptide-free cell culture media comprising at least 0.5 mg/L of a polyamine. The invention also relates to methods for expressing at least one protein in a medium comprising at least 0.5 mg/L of a polyamine and to methods for producing at least one virus in a medium comprising at least 0.5 mg/L of a polyamine. | 06-23-2011 |
| 20110144570 | SYSTEMS AND METHODS FOR PERFORMING PERITONEAL DIALYSIS - Systems and methods for providing multiple pass continuous flow dialysis therapy are provided. The present invention includes a fluid circuit connected to a patient via a catheter thereby defining a fluid loop along which a therapy fluid including a dialysate can be continuously circulated into, through and out of a peritoneal cavity of a patient to remove a therapeutically effective amount of excess water and solutes including uremic toxins. The feed rate and discharge rate of therapy fluid into the fluid loop can be controllably regulated in proportion to the circulation rate of fluid in the fluid loop such that the therapy fluid can pass a multiple number of times along the fluid loop prior to discharge. | 06-16-2011 |
| 20110144569 | PERITONEAL DIALYSIS MACHINE TOUCH SCREEN USER INTERFACE - A peritoneal dialysis machine including a membrane pump and a touch screen display that includes a mode-indicating portion and an operation-descriptive portion, the mode-indicating portion having a plurality of touch sensitive indicia each indicating one of a plurality of modes in which the machine can operate, the display being used to keep a patient continually informed of which one mode of at least three operating modes the machine is operating in, as the operation-descriptive portion changes to display details of a specific operation being carried out within the one mode, the indicia for each of the three operating modes always being visible to the patient while the machine is operating, the operating mode being selected by the patient touching one of the indicia on the screen. | 06-16-2011 |
| 20110144557 | DIALYSIS SYSTEMS AND METHODS INCLUDING CASSETTE WITH FLUID HEATING AND AIR REMOVAL - A dialysis fluid system includes an instrument including a pump actuator and a fluid heater, and a dialysis fluid cassette. The dialysis fluid cassette includes a rigid portion defining a pumping section for operation with the pump actuator and a heating section for operation with the fluid heater. The heating section includes a dialysis fluid inlet, a dialysis fluid outlet, and a dialysis fluid heating area located between the fluid inlet and the fluid outlet, the heating section further includes an air separation chamber for collecting air separated from the dialysis fluid. | 06-16-2011 |
| 20110141116 | METHODS AND APPARATUS FOR DISPLAYING FLOW RATE GRAPHS AND ALARMS ON A DIALYSIS SYSTEM - The present disclosure provides methods and apparatus for displaying flow rate graphs and alarms on a dialysis system. The disclosed methods and apparatus allow a user to simultaneously view a normal flow rate graph, one or more abnormal flow rate graphs, an actual flow rate graph, and an alarm type. Preferably, the three graphs are at the same scale and time-aligned so the user can quickly diagnose issues associated with drain and catheter problems. | 06-16-2011 |
| 20110137241 | SYSTEM AND METHOD FOR DETECTING OCCLUSION USING FLOW SENSOR OUTPUT - A method of detecting an occlusion for an infusion therapy in one embodiment includes: monitoring an output signal from a flowrate sensor for a pulsatile fluid flow having a frequency range, the pulsatile flow being through a fluid pathway to a patient; acquiring a data set that includes the output signal as a function of time; filtering the data set with a noise rejection filter to produce a filtered data set; performing spectra analysis on the filtered data set to determine a strength of the output signal in a frequency domain; calculating a signal strength for the frequency range using the strength of the output signal in the frequency domain; and comparing the signal strength of the range to at least one threshold level to determine if an occlusion is present during the infusion therapy. | 06-09-2011 |
| 20110137237 | DIALYSIS SYSTEMS AND METHODS HAVING VIBRATION-AIDED AIR REMOVAL - A dialysis system includes a dialysis fluid disposable configured to hold and transport a dialysis fluid; an air separation chamber in fluid communication with the dialysis fluid disposable; and a dialysis instrument operable to pump dialysis fluid through the dialysis fluid disposable, the instrument including a vibrator configured to vibrate the air separation chamber to separate air from the dialysis fluid traveling through the chamber. | 06-09-2011 |
| 20110137236 | FLUID DELIVERY SYSTEMS AND METHODS HAVING FLOATING BAFFLE AIDED AIR REMOVAL - A medical fluid delivery system includes a fluid disposable configured to hold and transport a medical fluid and an air separation chamber in fluid communication with the fluid disposable. The air separation chamber includes at least one fluid baffle floating within the air separation chamber and configured to separate air from medical fluid traveling through the chamber. | 06-09-2011 |
| 20110132841 | DIALYSIS SYSTEM INCLUDING MULTI-HEATER POWER COORDINATION - A dialysis system includes a first fluid heater, a second fluid heater, a supplemental power source and a logic implementer. The logic implementer is configured to use the supplemental power source such that when the first and second heaters are powered simultaneously, a collective current draw does not exceed a maximum allowable current draw of a branch power source powering the system | 06-09-2011 |
| 20110131058 | THERAPY MANAGEMENT SYSTEM AND METHOD FOR PERITONEAL DIALYSIS - A method for organizing care for a patient undergoing a peritoneal dialysis therapy under a system including at least one display device, at least one memory device, at least one processor and at least one peritoneal dialysis instrument for performing the peritoneal dialysis therapy, the method comprising: organizing information for presentation in a plurality of screens using the at least one display device, the at least one memory device, and the at least one processor, wherein each screen presents information pertinent to a particular aspect of the peritoneal dialysis therapy; and displaying in the plurality of screens information about the patient's prescription for the peritoneal dialysis therapy, information about medication the patient is taking in connection with the peritoneal dialysis therapy, and information about the patient's compliance with the peritoneal dialysis therapy. | 06-02-2011 |
| 20110125103 | DRIP CHAMBER WITH FLOW CONTROL - A flow control system includes a drip chamber having lower and upper wall sections and a collapsible wall extending between the lower and upper wall sections, a downwardly depending valve seat attached to the lower wall section, and a valve member disposed in the drip chamber, attached to the upper wall section and having a valve surface engageable with the valve seat. The system also includes a driver rotatably engaged to the lower and upper wall sections. Upon rotation of the driver in a first direction, the collapsible wall of the drip chamber moves between a collapsed condition in which the valve seat is sealingly engaged with the valve surface and an extended condition in which the valve seat is sufficiently spaced from the valve surface to form a flow passageway between the valve surface and the valve seat and permit flow through the opening of the drip chamber. | 05-26-2011 |
| 20110117594 | PROBE CONNECTOR ASSEMBLY AND MEHTOD OF USE - A probe assembly includes a tubular sleeve having a passage extending between a first end and an opposing second end. The tubular sleeve is movable between an extended position wherein the first end and the opposing second end are spaced apart and a collapsed position wherein the first end and the opposing second end are moved closer together. A connector is secured to the second end of the tubular sleeve, the connector having an opening extending therethrough that communicates with the passage of the tubular sleeve, a sealing layer removably covering the opening of the connector. An elongated probe has a first end and an opposing second end, the second end of the probe being positioned within the passage of the tubular sleeve, the second end of the probe being configured to pass through the opening of the connector when the sealing layer is removed therefrom. | 05-19-2011 |
| 20110117027 | INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION - The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present application exhibits physical characteristics, such as mechanical properties, typically seen in elastomers and mechanical stability, which is superior to fibrin alone. A variety of properties of the composition of the present invention can be effectively fine-tuned and altered by adjusting type and content of the particles as well as of the plasticizer contained in the void filler composition. | 05-19-2011 |
| 20110112489 | INTERLOCKING TUBING CLAMPS - A tube clamp includes (i) a tube holding portion; (ii) a first arm extending from a first end of the tube holding portion; (iii) a second arm extending from a second end of the tube holding portion, the second armed curved so that a first catch located at a distal end of the second arm can be snap-fitted to the first arm to occlude a first tube extending through the tube holding portion; and (iv) wherein the first arm includes a locking feature configured such that when a second tube clamp is mated with the tube clamp, the locking feature interacts with a second catch of the second tube clamp so that the second tube clamp is prevented from occluding a second tube. | 05-12-2011 |
| 20110112028 | FACTOR VIII POLYMER CONJUGATES - The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same. | 05-12-2011 |
| 20110112027 | FACTOR VIII POLYMER CONJUGATES - The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same. | 05-12-2011 |
| 20110112026 | FACTOR VIII POLYMER CONJUGATES - The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same. | 05-12-2011 |
| 20110112025 | FACTOR VIII POLYMER CONJUGATES - The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same. | 05-12-2011 |
| 20110112024 | FACTOR VIII POLYMER CONJUGATES - The invention is a proteinaceous construct comprising a Factor VIII molecule which is conjugated to a water-soluble polymer via carbohydrate moieties of Factor VIII, and methods of preparing same. | 05-12-2011 |
| 20110111455 | Polymer-Von Willebrand Factor-Conjugates - The present invention relates to a proteinaceous construct (also designated as polymer-VWF-conjugate) comprising plasmatic and/or recombinant von Willebrand factor (VWF), said VWF being bound to at least one physiologically acceptable polymer molecule, as well as to a complex between said proteinaceous construct and at least one factor VIII (FVIII) protein. The physiologically acceptable polymer molecule can be, for instance, polyethylene glycol (PEG) or polysialic acid (PSA). Further the present invention relates to methods for prolonging the in vivo-half-life of VWF or FVIII in the blood of a mammal having a bleeding disorder associated with functional defects of or deficiencies of at least one of FVIII or VWF. | 05-12-2011 |
| 20110106003 | DIALYSIS SYSTEM AND METHOD FOR CASSETTE-BASED PUMPING AND VALVING - A peritoneal dialysis system includes a disposable cassette including a flexible sheet; a hardware unit including (i) at least one pump actuator and piston head moved by the pump actuator, (ii) at least one valve actuator, (iii) at least one sensor, and (iv) a disposable cassette interface for interfacing with the disposable cassette, the disposable cassette interface including: (a) at least one pump aperture, the at least one piston head moveable out of and retractable into the at least one pump aperture to move a corresponding pumping portion of the flexible sheet of the disposable cassette, the piston head moving within a vacuum chamber, the vacuum chamber enabling a vacuum to be pulled around the piston head to the flexible sheet of the disposable cassette; (b) at least one valve aperture, at least a portion of the at least one valve actuator located in the valve aperture to move a valve portion of the flexible sheet of the disposable cassette; and (c) at least one sensor aperture, the at least one sensor located in the at least one sensor aperture, the at least one sensor operable with a sensor portion of the flexible sheet of the disposable cassette. | 05-05-2011 |
| 20110105983 | HEMODIALYSIS SYSTEM INCLUDING ON-LINE DIALYSATE GENERATION - A hemodialysis system includes an on-line dialysate generator; a dialysate pump actuator configured to pump dialysate generated by the generator to a dialyzer; a conductivity sensor located adjacent to a temperature sensor upstream of the dialyzer; a blood pump actuator; an air detector; and a disposable cassette configured to carry dialysate pumped by the dialysate pump actuator, the disposable cassette including a conductivity sensor portion and a temperature sensor portion located to operate with the conductivity sensor and the temperature sensor, respectively, the disposable cassette further configured to carry blood pumped by the blood pump actuator and to provide an air detection portion located to operate with the air detector. | 05-05-2011 |
| 20110093294 | PERITONEAL DIALYSIS OPTIMIZED USING A PATIENT HAND-HELD SCANNING DEVICE - A dialysis system includes: a portable device configured to be carried by a patient and to read a marking displayed on a dialysis fluid container, the device obtaining data concerning at least one of a dialysis fluid type and a dialysis fluid volume from the marking; the device defined dialysate dwell time, alert patients for the next exchange and further configured to transfer the data to a computer; and wherein the computer is configured to use the data to track therapy progress of the product. | 04-21-2011 |
| 20110092907 | THERAPY MANAGEMENT DEVELOPMENT PLATFORM - A method of providing therapy management development includes providing a therapy management development platform having a plurality of levels of functionality, the platform including a medical device capable of providing therapy management, setting the platform to a first level of access to the functionality relative to the medical device, and modifying the operation of the medical device using the platform. The method also includes receiving an indication of approval to change the level of access to the functionality of the platform to a second level of access, and setting the platform to the second level of access to the functionality of the platform in response to receipt of the indication of approval. The platform is also provided. | 04-21-2011 |
| 20110092895 | DIALYSIS SYSTEMS HAVING SPIRALING FLUID AIR SEPARATION CHAMBERS - A dialysis fluid cassette includes a rigid portion defining at least one valve chamber, the rigid portion further defining an air separation chamber, the air separation chamber when in an operating position including an inner surface, a fluid inlet and a fluid outlet and configured to cause a dialysis fluid to spiral around the inner surface toward the fluid outlet, such that air is removed from the dialysis fluid. | 04-21-2011 |
| 20110092681 | Purification of VWF for Increased Removal of Non-Lipid Enveloped Viruses - The present invention provides methods for purifying Von Willebrand factor (VWF) for increased removal of non-lipid enveloped viruses. | 04-21-2011 |
| 20110091427 | METHODS FOR TREATING A KIDNEY INJURY - Provided herein are methods of treating a kidney injury in a patient, comprising administering to the patient hematopoietic stem cells (HSCs) in an amount effective to treat the kidney injury. In some embodiments, administration of the HSCs is delayed, such that the HSCs are not administered immediately after the kidney injury. In certain aspects, the HSCs are administered to the patient during the beginning of the repair phase of the kidney. Further embodiments and aspects of the invention, including related methods and compositions for use therein, are described herein. | 04-21-2011 |
| 20110086413 | Cell Culture Medium For ADAMTS Protein Expression - The present invention provides culture mediums that are useful for the expression of ADAMTS proteins, such as ADAMTS13. Methods for the expression and purification of ADAMTS proteins are also provided. In some embodiments, the mediums and methods of the invention are useful for the expression of ADAMTS proteins having high specific activities. Also provided are ADAMTS, e.g., ADAMTS13, protein compositions with high specific activities, which are expressed and purified according to the methods provided herein. | 04-14-2011 |
| 20110086411 | Method of Producing a Polypeptide or Virus of Interest in a Continuous Cell Culture - Described herein is a chemostat-like continuous cell culture system that combines certain advantages of perfusion open systems and chemostat open systems to improve the culturing of mammalian cells, e.g., genetically modified cells, particularly in serum-free or chemically-defined media. The continuous culture system described herein involves culturing mammalian cells in a continuous cell culture system, which comprises a cell retention device, wherein the cell culture system has a dilution rate (D) of less than about 2 d | 04-14-2011 |
| 20110081722 | ANIMAL PROTEIN-FREE MEDIA FOR CULTIVATION OF CELLS - The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as recombinant cells or cells infected with a virus, and for producing biological products by cell culture processes. | 04-07-2011 |
| 20110081700 | Methods of Purifying Recombinant Adamts13 and Other Proteins and Compositions Thereof - Provided herein are methods for purifying recombinant A Disintegrin-like and Metallopeptidase with Thrombospondin Type 1 Motif 13 (ADAMTS13) protein from a sample. The method comprises enriching for ADAMTS13 protein by chromatographically contacting the sample with hydroxyapatite under conditions that allow ADAMTS13 protein to appear in the eluate or supernatant from the hydroxylapatite. The methods may further comprise tandem chromatography with a mixed mode cation exchange/hydrophobic interaction resin that binds ADAMTS13 protein. Additional optional steps involve ultrafiltration/diafiltration, anion exchange chromatography, cation exchange chromatography, and viral inactivation. Also provided herein are methods for inactivating virus contaminants in protein samples, where the protein is immobilized on a support. Also provided herein are compositions of ADAMTS13 prepared according to said methods. | 04-07-2011 |
| 20110081680 | Animal Protein-Free Media For Cultivation of Cells - The present invention relates to animal protein-free cell culture media comprising polyamines and a plant- and/or yeast-derived hydrolysate. The invention also relates to animal protein-free culturing processes, wherein cells can be cultivated, propagated and passaged without adding supplementary animal proteins in the culture medium. These processes are useful in cultivating cells, such as recombinant cells or cells infected with a virus, and for producing biological products by cell culture processes. | 04-07-2011 |
| 20110076719 | Substantially Animal Protein-Free Recombinant Furin and Methods for Producing the Same - The present invention relates to recombinant furin (rFurin) and methods for producing rFurin. More specifically, the invention relates to substantially animal protein-free rFurin and methods for producing substantially animal protein-free rFurin. | 03-31-2011 |
| 20110072524 | Transgenic Mouse Lacking Endogenous FVIII and VWF - A Model of Hemophilia A - The present invention relates, generally, to a transgenic non-human animal model of hemophilia A, wherein the transgenic animal is deficient in endogenous Factor VIII and endogenous von Willebrand Factor, and methods to treat hereditary or acquired hemophilia A or von Willebrand Disease (VWD) by administration of exogenous human VWF. | 03-24-2011 |
| 20110070592 | DETECTION OF ANTIBODY THAT BINDS TO WATER SOLUBLE POLYMER-MODIFIED POLYPEPTIDES - The present invention provides analytical methods for detecting anti-polymer antibody in an individual. The methods involve contacting a sample from the individual with a water soluble polymer-modified carrier and detecting binding of antibody to the water soluble polymer on the water soluble polymer-modified carrier wherein binding is indicative of the presence of antibody to the water polymer-modified polypeptide. Antibody may be detected to water soluble polymers such as polyethylene glycol, polysialic acid, dextran, hydroxyalkyl starch, or hydroxyethyl starch. When antibody to the water soluble polymer polyethylene glycol is to be detected, the carrier is modified with a non-linear polyethylene glycol derivative. | 03-24-2011 |
| 20110064714 | FACTOR VIIA-POLYSIALIC ACID CONJUGATE HAVING PROLONGED IN VIVO HALF-LIFE - The present invention relates to a proteinaceous construct comprising plasmatic or recombinant factor VIIa (FVIIa) or biologically active derivatives thereof, which are bound to a carbohydrate moiety comprising 1-4 sialic acid units, wherein the in vivo half-life of the proteinaceous construct is substantially prolonged in the blood of a mammal, as compared to the in vivo half-life of a FVIIa molecule not bound to a carbohydrate moiety. The invention also provides a method for controlling bleeding in a mammal having a bleeding disorder due to functional defects or deficiencies of FVIIa, FVIII, or FIX. The invention also provides a method for controlling bleeding in a mammal during surgery or trauma. | 03-17-2011 |
| 20110064608 | DIALYSIS CONNECTOR AND CAP COMPATIBLE WITH GAS STERILIZATION - A dialysis disposable sterilization method including: fitting a cap to a connector such that a cap/connector interface can hold a pressure; applying a sterilizing gas through an inside of the connector such that the gas flows through (i) the inside of the connector, (ii) around to the outside of the connector, (iii) past a stabilization rib, and (iv) into contact with one side of the cap/connector interface; and applying the sterilizing gas at an outside of the cap such that the sterilizing gas flows around a bottom of the cap and contacts an opposing side of the cap/connector interface. | 03-17-2011 |
| 20110060361 | RECONSTITUTION AND APPLICATOR SYSTEM FOR WOUND SEALANT PRODUCT - A system for mixing or reconstituting agents including engageable syringe barrels, one of which having a male engagement region and the other a female engagement region. Each of the male and female engagement regions is provided with a screen. The screens are closely spaced from one another when the first and second syringe barrels are engaged with one another. The screens may take the form of a mesh, a plurality of protuberances, or cantilevered wedges having tapering thicknesses. | 03-10-2011 |
| 20110048949 | DIALYSIS TREATMENT DEVICES FOR REMOVING UREA - Dialysis treatment devices and methods for removing urea from dialysis waste streams are provided. In a general embodiment, the present disclosure provides a dialysis treatment device including a first cell having a first electrodialysis unit, a second cell having at least one of a urease compartment and a sorbent compartment and in fluid communication with the first cell, and a third cell having a second electrodialysis unit and in fluid communication with the second cell. | 03-03-2011 |
| 20110040244 | AUTOMATED DIALYSIS SYSTEM INCLUDING A PISTON AND STEPPER MOTOR - A peritoneal dialysis system includes a hardware unit including a piston having a contact surface and a stepper motor configured to move the piston; and a disposable unit received by the hardware unit, the disposable unit including a moveable membrane operable with the contact surface of the piston, the piston moveable towards and away from the disposable unit, wherein (i) the piston and the membrane are positioned relative to each other and (ii) the hardware unit is configured to apply a negative pressure to the moveable membrane of the disposable unit so that the negative pressure causes the moveable membrane to contact and conform to a shape of the contact surface and to follow the piston as the piston is moved away from the disposable unit by the stepper motor, and wherein the shape-contacted membrane moves with the piston as the piston is moved into the disposable unit by the stepper motor. | 02-17-2011 |
| 20110040243 | AUTOMATED DIALYSIS SYSTEM INCLUDING A PISTON AND VACUUM SOURCE - A peritoneal dialysis system includes a hardware unit including a piston and at least one vacuum source; a door connected to the hardware unit, the door including a cavity, the cavity having a diameter; the hardware unit further including a structure positioned opposite the door, the structure defining an aperture; a disposable unit including first and second fluid receiving membranes, the disposable unit disposed between the structure and the door; the at least one vacuum source operable to apply a vacuum to at least one of the first and second membranes of the disposable unit; the piston, at least a portion of which moves through the aperture, in operation contacting one of the membranes, the piston including a piston head having a diameter smaller than the diameter of the cavity in the door; and a dialysis fluid opening enabling dialysis fluid to be pulled in between the first and second membranes. | 02-17-2011 |
| 20110038755 | CONTAINERS COMPRISING PEELABLE SEALS - Multi-chambered containers having peelable seals and methods of sterilizing the same are provided. In an embodiment, the present disclosure provides a flexible fluid container comprising a first chamber and a second chamber. The second chamber is attached to a tube for providing fluid communication from the second chamber to the exterior of the container. The first chamber and the second chamber are separated by a first peelable seal having a channel so constructed and arranged to allow a controlled quantity of fluid to pass therethrough. | 02-17-2011 |
| 20110033551 | NUCLEIC ACID MICROSPHERES, PRODUCTION AND DELIVERY THEREOF - Nucleic acids are prepared by dissolving compounds containing them in a suitable solvent or solvent system and forming microspheres from the resulting solution. The microspheres are administered to an individual as protection from conditions where delivery of nucleic acids is useful, such as in treatment of autoimmune disease. | 02-10-2011 |
| 20110028892 | PERITONEAL DIALYSIS SYSTEM HAVING CASSETTE-BASED-PRESSURE-CONTROLLED PUMPING - A peritoneal dialysis system includes a removable cassette defining a flexible pump chamber and a pressure sensing area that is fluidly connected to the pump chamber wherein, during operation of the peritoneal dialysis system, peritoneal dialysis fluid is contained in the pump chamber; and a peritoneal dialysis machine configured to secure the removable cassette, peritoneal dialysis machine including (i) a pressure sensor positioned to align with and to contact the pressure sensing area of the removable cassette when the removable cassette is secured to the peritoneal dialysis machine, and (ii) a controller connected to the pressure sensor and adapted to change the operation of the peritoneal dialysis machine in response to changes in pressure sensed by the pressure sensor, wherein the pressure sensor and the pressure sensing area are arranged so that the pressure sensor measures a pressure of fluid in a fluid passage between the pump chamber and a patient during operation of the peritoneal dialysis system. | 02-03-2011 |
| 20110028693 | BLOOD COAGULATION PROTEIN CONJUGATES - The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a blood coagulation protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer. In one embodiment of the invention the conjugation is carried out in the presence of the nucleophilic catalyst aniline. In addition the generated oxime linkage can be stabilized by reduction with NaCNBH | 02-03-2011 |
| 20110027350 | GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS - A water soluble polymer, in particular polysialic acid (PSA) or a modified PSA (mPSA), is conjugated to an oxidized carbohydrate moiety of a glycoprotein other than a blood coagulation protein or to a ganglioside or drug delivery system by contacting the oxidized carbohydrate moiety with the water soluble polymer, wherein said water soluble polymer contains an aminooxy group and an oxime linkage is formed between the oxidized carbohydrate moiety and the aminooxy group on the water soluble polymer or wherein said water soluble polymer contains a hydrazide group and a hydrazone linkage is formed between the oxidized carbohydrate moiety and the hydrazide group on the water soluble polymer. Conjugates of aminooxy- or hydrazide-water soluble polymer, such as PSA and mPSA, are thus obtained in which the PSA or mPSA is attached via a carbohydrate moiety. | 02-03-2011 |
| 20110010101 | SIMPLIFIED PERITONEAL EQUILIBRATION TEST FOR PERITONEAL DIALYSIS - A simplified peritoneal equilibration test (S-PET) is disclosed. Instead of a lengthy peritoneal equilibration test (PET), the simplified procedure requires no blood sample and may use data from as few as two or three samples to classify a peritoneal membrane of a user. Typically, a peritoneal membrane or peritoneum of a dialysis patient, or other person, is classed as a high transport membrane, high-average transport membrane, a low-average transport membrane or a low transporter membrane. The S-PET may be performed at home by a user without the need to submit a blood sample. Kits for analyzing the samples may be furnished for home use. The kits may use disposable strips, microfluidic analyzers or chemical reagents, or may alternatively include reusable analysis equipment, such as optical or conductivity analysis equipment. | 01-13-2011 |
| 20110009810 | PERITONEAL DIALYSIS THERAPY WITH LARGE DIALYSIS SOLUTION VOLUMES - Patients suffering from acute renal failure must be diagnosed and treated quickly so that a physician can confidently prescribe either peritoneal dialysis or hemodialysis. In one way of quickly treating the patients, software is used to calculate a suitable peritoneal dialysis prescription without regard to how short or how long a dialysis cycle is used, and without regard to a total dialysate fluid volume for a therapy. For patients with suitable peritoneal membrane transport properties, the software program suggests that, at least over a short period of time, unexpectedly high ultrafiltrate volumes and high clearances may be achieved. | 01-13-2011 |
| 20110009798 | RENAL THERAPY SYSTEM HAVING PUMP REVERSING FLUID CONTROL - A renal therapy system includes: a filter; an arterial blood flowpath in fluid communication with the filter; a venous blood flowpath in fluid communication with the filter; extracorporeal circuit including the filter, the arterial blood flowpath and the venous blood flowpath; a renal therapy fluid flowpath in fluid communication with the extracorporeal circuit; a plurality of renal therapy fluid valves; and first and second renal therapy fluid pumps, wherein the system is configured to operate the plurality of renal therapy fluid valves so that (i) the first renal therapy fluid pump pumps renal therapy fluid through the renal therapy fluid flowpath to the extracorporeal circuit for a number of first pump actuations and (ii) the second renal therapy fluid pump pumps renal therapy fluid through the renal therapy fluid flowpath for a number of second pump actuations. | 01-13-2011 |
| 20110009797 | DIALYSIS SYSTEM INCLUDING BLOOD AND DIALYSATE CASSETTE - A dialysis system including a dialysis machine including a blood pump actuator, dialysate pump actuator, a blood valve actuator and a dialysate valve actuator; and a disposable cassette operable with the dialysis machine, the disposable cassette including: (i) a housing, (ii) a dialysate pump portion of the housing configured to operate with the dialysate pump actuator, (iii) a blood valve portion of the housing configured to operate with the blood valve actuator, (iv) a dialysate valve portion of the housing configured to operate with the dialysate valve actuator, (v) a dialyzer supported by the housing, the dialyzer including a dialysate inlet and a dialysate outlet, (vi) a first dialysate connection extending externally from the housing to the dialyzer inlet, and (vii) a second dialysate connection extending externally from the housing to the dialyzer outlet. | 01-13-2011 |
| 20110005992 | DIALYSIS SYSTEM WITH BALANCE CHAMBER PRIME AND RINSEBACK - A dialysis system includes an extracorporeal circuit including a dialyzer; a dialysis fluid circuit including a first balance chamber, a second balance chamber, a fresh dialysis fluid pump in fluid communication with first and second fresh compartments of the first and second balance chambers, respectively, the first and second fresh compartments in fluid communication with a fresh dialysate fluid inlet of the dialyzer, and a spent dialysis fluid pump in fluid communication with first and second spent compartments of the first and second balance chambers, respectively, the spent dialysis fluid pump also in fluid communication with a spent dialysis fluid outlet of the dialyzer; and wherein the system is configured to run a priming sequence that uses (i) at least one of the fresh and spent dialysis fluid pumps and the first and second balance chambers to pump dialysis fluid through the dialysis fluid circuit and (ii) at least one of the fresh and spent dialysis fluid pumps to pump dialysis fluid through the dialyzer and into the extracorporeal circuit. | 01-13-2011 |
| 20110005986 | DIALYSIS SYSTEM WITH CASSETTE BASED BALANCE CHAMBERS AND VOLUMETRIC PUMPS - A dialysis system includes a fresh dialysis fluid membrane pump; a spent dialysis fluid membrane pump; a first balance chamber having a fresh dialysis fluid compartment connected fluidly to the fresh dialysis fluid membrane pump and a spent dialysis fluid compartment connected fluidly to the spent dialysis fluid membrane pump; a second balance chamber having a fresh dialysis fluid compartment connected fluidly to the fresh dialysis fluid membrane pump and a spent dialysis fluid compartment connected fluidly to the spent dialysis fluid membrane pump; and a dialysis fluid cassette, wherein at least one of the fresh dialysis fluid membrane pump, the spent dialysis fluid membrane pump, the first balance chamber and the second balance chamber includes a fluid receiving portion provided in the dialysis fluid cassette. | 01-13-2011 |
| 20110004351 | DIALYSIS SYSTEM INCLUDING DOWNLOADED PRESCRIPTION ENTRY - A dialysis system includes a dialysis fluid cassette-based membrane blood pump; a dialyzer in fluid communication with the blood pump; first and second dialysis fluid cassette-based balance chambers each having (i) a fresh dialysis fluid compartment in fluid communication with the dialyzer and (ii) a spent dialysis fluid compartment; a dialysis fluid cassette-based fresh dialysis fluid membrane pump in fluid communication with the fresh dialysis fluid compartments of the first and second balance chambers; a dialysis fluid cassette-based spent dialysis fluid membrane pump in fluid communication with the dialyzer and the spent dialysis fluid compartments of the first and second balance chambers; and which is configured to receive a data transfer including a prescription entry for the system. | 01-06-2011 |
| 20110000832 | DIALYSIS SYSTEM WITH ENHANCED FEATURES - A dialysis system includes a dialysis fluid cassette-based membrane blood pump; a dialyzer in fluid communication with the blood pump: first and second dialysis fluid cassette-based balance chambers each having (i) a fresh dialysis fluid compartment in fluid communication with the dialyzer and (ii) a spent dialysis fluid compartment; a dialysis fluid cassette-based fresh dialysis fluid membrane pump in fluid communication with the fresh dialysis fluid compartments of the first and second balance chambers; a dialysis fluid cassette-based spent dialysis fluid membrane pump in fluid communication with the dialyzer and the spent dialysis fluid compartments of the first and second balance chambers; and arterial and venous lines in fluid communication with the dialyzer for patient connection, the arterial and venous lines each including a contact used for electrically detecting a patient access disconnection. | 01-06-2011 |
| 20100330071 | METHOD TO PRODUCE A HIGHLY CONCENTRATED IMMUNOGLOBULIN PREPARATION FOR SUBCUTANEOUS USE - The present invention relates to a new and improved method for preparing a highly concentrated immunoglobulin composition from pooled plasma for subcutaneous injection. A composition comprising 20% or more immunoglobulin suitable for subcutaneous use is also described. | 12-30-2010 |
| 20100326868 | Packaging System - A packaging system includes a vial with a rim about an upper open end, and a neck between a lower closed end and the rim. The vial contains a pharmaceutical product. A valve is disposed over the open end, and a crimp ring is disposed over the valve with an opening defining an access port. A detachable cap is disposed over the access port. A single tubular label is disposed about the vial, and extends only from a first edge aligned with the closed end to a second edge at the cap. The label has first and second sections separated by a single circumferential perforated boundary aligned with the neck. The first section is backed with an adhesive and attached to the outer vial surface, and extends between the closed end and the boundary. The second section extends at least between the boundary and the cap. | 12-30-2010 |
| 20100319695 | Adapters for Use with an Anesthetic Vaporizer - An adapter includes a base connectable to an anesthetic agent container, a spout that extends from the base and defines at least one flow path therethrough, and a valve assembly disposed within the at least one flow path, the valve assembly being moveable between a first open position and a second closed position. The adapter also includes a radially expandable seal disposed about the spout, the seal having a first end, a second end, and an intermediate region between the first and second ends that expands radially outward relative to a longitudinal axis of the spout. The valve assembly has a surface that cooperates with the seal, wherein the cooperation between the surface and the seal expands the intermediate region radially outward relative to the longitudinal axis with the valve assembly in the first position. | 12-23-2010 |
| 20100318048 | HEMOSTATIC SPONGE - The present invention provides a hemostatic porous sponge comprising a matrix of a fibrous biomaterial and particles of a fluid absorbing, particulate material adhered to said matrix material, a method of producing these sponges and their use for wound healing. | 12-16-2010 |
| 20100317081 | Counter-Pressure Filtration of Proteins - A method is disclosed for filtering a protein in a liquid mixture in a manner that does not substantially damage or otherwise limit the recovery of the protein in the filtration filtrate. The method generally includes passing a liquid mixture containing a protein (e.g., an aqueous vWF mixture) through a filter while applying a counter pressure to the liquid mixture filtrate to accurately reduce and control the pressure differential across the filter. The disclosed method has the advantage that relatively high filtration flow rates can be achieved at relatively low pressure differentials, in contrast to high pressure differentials, which actually reduce the filtration flow rate of protein liquid mixtures. Further, the method can recover substantially all of the protein that is initially present in the liquid mixture. | 12-16-2010 |
| 20100314317 | Counter-Pressure Filtration of Proteins - A method is disclosed for filtering a protein in a liquid mixture in a manner that does not substantially damage or otherwise limit the recovery of the protein in the filtration filtrate. The method generally includes passing a liquid mixture containing a protein (e.g., an aqueous vWF mixture) through a filter while applying a counter pressure to the liquid mixture filtrate to accurately reduce and control the pressure differential across the filter. The disclosed method has the advantage that relatively high filtration flow rates can be achieved at relatively low pressure differentials, in contrast to high pressure differentials, which actually reduce the filtration flow rate of protein liquid mixtures. Further, the method can recover substantially all of the protein that is initially present in the liquid mixture. | 12-16-2010 |
| 20100314314 | DIALYSIS TREATMENT DEVICES FOR REMOVING UREA - Dialysis treatment devices and methods for removing urea from dialysis waste streams are provided. In a general embodiment, the present disclosure provides a dialysis treatment device including: 1) a first filter having a filtration membrane, 2) a urea removal unit having urease and in fluid communication with the first filter, and 3) a second filter having an ion rejection membrane and in fluid communication with the first filter and the urea removal unit. | 12-16-2010 |
| 20100308243 | SOLENOID PINCH VALVE APPARATUS AND METHOD FOR MEDICAL FLUID APPLICATIONS HAVING REDUCED NOISE PRODUCTION - A low noise solenoid valve system includes a solenoid valve; and a controller configured to perform a power actuation sequence in which power to the solenoid valve undergoes a plurality of cycles that switch from an actuation level power to a hold level power, wherein the actuation level power is increased at each subsequent cycle, and wherein the actuation power level of one of the plurality of cycles is sufficient to fully actuate the solenoid valve. | 12-09-2010 |
| 20100301268 | MULTI-PART SUBSTITUTION INFUSION FLUIDS AND MATCHING ANTICOAGULANTS - A multi-part substitution infusion fluid for an extracorporeal blood treatment and methods for using same are provided. Generally, the multi-part substitution fluid comprises a first solution composed of electrolites but without divalent cations and a second solution comprising divalent cations. Another embodiment includes a third solution comprising a matching citrate/citric acid anticoagulant. The described methods of using the multi-part substitution infusion fluids significantly reduce risks associated with various extracorporeal blood treatments. | 12-02-2010 |
| 20100298662 | SYSTEM AND METHOD FOR AUTOMATED DATA COLLECTION OF TWENTY-FOUR HOUR ULTRAFILTRATION AND OTHER PATIENT PARAMETERS USING WIRED OR WIRELESS TECHNOLOGY - A dialysis system includes: a dialysis machine for performing a first dialysis session on a patient at a first time of a day; a remote exchange device for performing a second dialysis session on the patient at a second time of the day, the remote exchange device configured to record an amount of ultrafiltration (“UF”) that is removed from the patient over the second dialysis session; and a communication link between the dialysis machine and the remote exchange device, wherein the dialysis machine is configured to receive the recorded amount UF removed from the remote exchange device via the communication link and determine a total amount of UF removed from the patient over the first and second sessions. | 11-25-2010 |
| 20100294277 | Container and Pharmaceutical Product - An anesthetic container includes a receptacle for holding the anesthetic and having a wall defining an interior space and a passage in fluid communication with the interior space. The container also includes a valve assembly that is attachable or is attached to the receptacle to control flow of anesthetic through the passage in the receptacle to a vaporizer. The valve assembly has a closed configuration when the flow of anesthetic from the receptacle is limited and an open configuration when the flow of anesthetic is enabled. The valve assembly is constructed so that at least the surface of any component of the assembly that will come into contact with the anesthetic on its storage or passage from the receptacle to the vaporizer is made of a metal or low-density polyethylene, and provides a fluid-tight seal to prevent the escape of the anesthetic without the use of a gasket in the closed configuration. | 11-25-2010 |
| 20100292717 | METHOD FOR THE IMPROVEMENT OF MESH IMPLANT BIOCOMPATIBILITY - The present invention provides a method of fixating a mesh implant to a tissue of a subject comprising attaching said mesh implant to said tissue, covering said mesh implant by an antiadhesive barrier, wherein said antiadhesive barrier is attached to said mesh implant by a biocompatible adhesive. | 11-18-2010 |
| 20100292674 | Needleless Connector with Slider - A needleless connector includes a housing having a housing passage with an open end, a slider disposed in the housing passage, and a mechanism to bias the slider toward the open end of the housing passage. The connector may also include a seal at the open end of the housing passage, the seal either cooperating with the slider to seal the open end of the connector, or sealing the open end of the connector without interaction with the slider, for example taking the form of a slit septum. | 11-18-2010 |
| 20100290983 | Compositions and Methods for Drug Delivery - The present disclosure is directed to surface-modified particles and to methods of making and using the same. The surface-modified particles comprise a particle core and a coating associated with the particle core, wherein the particle core comprises an active agent, the coating comprises a surfactant having formula I, and the surface-modified particle has an average size from about 1 nm to about 2,000 nm: | 11-18-2010 |
| 20100286648 | PHARMACEUTICAL PRODUCT AND METHOD OF USE - A pharmaceutical product includes a container. The container, in turn, includes a receptacle having a wall including a layer of nickel or nickel alloy, the layer facing an interior of the receptacle. The product also includes a halogenated anesthetic selected from the group consisting of sevoflurane, desflurane, isoflurane, enflurane, methoxyflurane and halothane disposed within the container. | 11-11-2010 |
| 20100273183 | DIAGNOSTIC ASSAY FOR ANTI-VON WILLEBRAND FACTOR CLEAVING PROTEASE (ADAMTS13) ANTIBODIES - This invention relates to a kit to be used in an assay system for determination of an anti-von Willebrand Factor-cleaving protease (“anti-vWF-cp”) antibody in a sample. The kit comprises vWF-cp and/or vWF-fragment(s) immobilized on a solid phase. The kit can be used in a method for determination of anti-vWF-cp antibodies from a patient, for the diagnosis of disorders associated with the occurrence of anti-vWF-cp-antibodies, and the differentiation of various forms of thrombotic microangiopathy. | 10-28-2010 |
| 20100271296 | USER INTERFACE POWERED VIA AN INDUCTIVE COUPLING - An operating machine, such as a medical machine or a dialysis machine, includes a housing for operating components of the machine and a moveable user interface or display for viewing and entering information concerning operation of the machine. Signals concerning operating information are wirelessly transmitted between the machine and the display using one of several techniques. Power is also transmitted wirelessly from the operating machine to the screen, or from a separate power source to the display. The wireless signals may be transmitted via induction, radio, infrared or optical means. | 10-28-2010 |
| 20100267995 | METHODS FOR PREPARING FLUORINATED VINYL ETHERS - A method for preparing a fluorinated vinyl ether compound comprising reacting a fluorinated ether substrate having (i) a hydrogen atom on a carbon atom that is alpha to an etheric oxygen and (ii) a fluorine atom on a carbon atom that is beta to the etheric oxygen, with an organolithium base to provide a reaction product comprising a fluorinated vinyl ether compound. | 10-21-2010 |
| 20100260855 | DELIVERY OF AS-OLIGONUCLEOTIDE MICROSPHERES TO INDUCE DENDRITIC CELL TOLERANCE FOR THE TREATMENT OF AUTOIMMUNE TYPE 1 DIABETES - AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to prevent an autoimmune diabetes condition in NOD mice in vivo and in situ. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations. | 10-14-2010 |
| 20100260768 | ANTI MIF ANTIBODIES - The present invention relates to monoclonal antibodies and antigen-binding portions thereof that specifically bind to the C-terminal or the center region of macrophage migration inhibitory factor (MIF). These anti-MIF antibodies and antigen-binding portions thereof further inhibit human MIF biological function. The invention also relates to isolated heavy and light chain immunoglobulins derived from anti-MIF antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to a method of identifying anti-MIF antibodies, pharmaceutical compositions comprising these antibodies and a method of using these antibodies and compositions for the treatment of MIF-related conditions. | 10-14-2010 |
| 20100258690 | SLIDE AND LOCK CLAMPS - Slide and lock clamps for attaching to supports are provided. In a general embodiment, the present disclosure provides a clamp including a base plate comprising a first cradle. A rod is secured to the base plate. A sliding carriage is movably connected to the rod. The sliding carriage includes a lever, a cam, and a movable lock constructed and arranged for releasably locking the sliding carriage in place on the base plate. A second cradle is movably connected to the rod and positioned next to the sliding carriage for securing a support between the second cradle and the first cradle. | 10-14-2010 |
| 20100252702 | RAPID ATTACH AND RELEASE CLAMPS - Rapid attach and release clamps for attaching to supports are provided. In a general embodiment, the present disclosure provides a clamp including a threaded rod, an arm pivotally attached to the threaded rod, and a knob having an exterior surface and an interior surface. The knob defines a passageway sized to fit the threaded rod. A lock comprises at least one thread and is rotatably attached to the interior surface of the knob. The lock is constructed and arranged to move between a closed position with the thread entering the passageway and engaging the threaded rod and an open position with the thread not entering the passageway. A lever is moveably attached to the clamp and constructed and arranged to rotate the lock about a pivot point. | 10-07-2010 |
| 20100247936 | NON-PVC FILMS WITH TOUGH CORE LAYER - Multilayer films comprising a core layer are provided. In an embodiment, the present disclosure provides a film having a core layer comprising a material selected from a rubber-modified polypropylene and a polymer blend. The polymer blend includes an elastomeric propylene-ethylene copolymer and a component selected from the group consisting of polypropylene random copolymers, styrene/ethylene-butylene/styrene block copolymers, and combinations thereof. | 09-30-2010 |
| 20100247935 | NON-PVC FILMS HAVING BARRIER LAYER - Films having peel seal layers and/or barrier layers are provided. In a general embodiment, the present disclosure provides a film comprising a barrier layer comprising a caprolactam-free nylon compound. | 09-30-2010 |
| 20100247824 | NON-PVC FILMS HAVING PEEL SEAL LAYER - Films having peel seal layers and/or barrier layers are provided. In a general embodiment, the present disclosure provides a film comprising a peel seal layer comprising a blend of a polypropylene random copolymer having a melting temperature greater than 145° C., a styrene-ethylene-butylene-styrene block copolymer, and an LLDPE having a melting temperature greater than 120° C. | 09-30-2010 |
| 20100246316 | DISPENSER, KIT AND MIXING ADAPTER - A system includes a source of at least a first component, and a mixer having an inlet coupled to the source of at least a first component and an outlet, the mixer including at least one mixing device and a source of at least a second component disposed between the inlet and the outlet. The at least one mixing device includes a three-dimensional lattice defining a plurality of tortuous, interconnecting passages therethrough. The at least one mixing device has physical characteristics to sufficiently mix the first and second components, which characteristics include a selected one or more of mean flow pore size, thickness and porosity. Also disclosed are a kit defined by the source and the mixer, in the form of a mixer adapter, and the mixer adapter alone. | 09-30-2010 |
| 20100241045 | RENAL THERAPY BLOOD CLEANSING SYSTEM WITH BALANCE CHAMBER AND BOLUS, RINSEBACK OR PRIME VOLUME FEATURE - A renal therapy blood cleaning system includes: a blood filtering device in communication with an extracorporeal circuit; a first pump configured to pump fluid to the blood filtering device; a second pump configured to pump fluid from the blood filtering device; a balance chamber in fluid communication with first and second lines, the first and second lines in fluid communication with the first and second pumps, respectively, the balance chamber configured to exchange like volumes of fresh and spent fluid; a plurality of valves; and a control scheme programmed to operate the plurality of valves to enable spent fluid taken from the balancing chamber through one of the first and second lines to be recirculated to the balance chamber through the other of the first and second lines to compensate for a volume of fresh fluid delivered to the blood filtering device. | 09-23-2010 |
| 20100239609 | Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification - The present invention provides a method for purification of a virus or virus antigen comprising providing a virus preparation and centrifugation of said virus preparation in a gradient of a sugar established by the addition of two or more buffered sugar layers of different concentration. The method leads to higher yields and reduces unwanted aggregation of the virus or virus antigen by increasing the volume of the peak pool. | 09-23-2010 |
| 20100239606 | Two-Step Temperature Profile for the Propagation of Viruses - The present invention provides a method for the production of a virus. The method includes providing a host cell that has been infected by the virus and cultivating the infected host cell at two different temperatures. The virus produced by the cultivation steps is subsequently collected. By using the dual temperature cultivation process, high titer and improved purity can be obtained. | 09-23-2010 |
| 20100233805 | METHOD OF ENHANCING CELL GROWTH USING ALKYL-AMINE-N-OXIDE (AANOX) - The present invention relates to a method to enhance cell growth in culture comprising adding an alkyl-amine-n-oxide (AANOx), such as dodecyldimethylamine oxide (DDAO), into the culture medium in an amount sufficient to improve cell growth. | 09-16-2010 |
| 20100233269 | MINERALIZED POLYMER PARTICLES AND THE METHOD FOR THEIR PRODUCTION - A process for mineralizing a particulate organic material includes providing particles of a non-porous, swellable organic material, and contacting the particles with a solution containing at least one cation and a solution containing at least one anion, thereby obtaining the mineralized particulate organic material. | 09-16-2010 |
| 20100229978 | INFUSION PUMP ACTUATORS, SYSTEM AND METHOD FOR CONTROLLING MEDICAL FLUID FLOWRATE - An infusion pump includes an actuator having an output shaft; a pump actuator having a length l | 09-16-2010 |
| 20100229366 | DIALYSIS METHOD HAVING SUPPLY CONTAINER AUTOCONNECTION - A method for connecting a plurality of solution line connectors to a plurality of supply line connectors of a dialysis system includes: translating a tip protector remover in a first direction towards the plurality of supply line connectors to remove a plurality of solution line tip protectors from the plurality of solution line connectors; locking the tip protector remover to each of a plurality of supply line tip protectors connected to the plurality of supply line connectors; translating the tip protector remover in a second direction towards the plurality of solution line connectors to remove the plurality of supply line tip protectors from the supply line connectors; translating the tip protector remover in a third direction different from the first and second directions; translating one of the plurality of solution line connectors and the plurality of supply line connectors the other of the solution line connectors and the supply line connectors to connect each of the solution line connectors to one of the supply line connectors. | 09-16-2010 |
| 20100227052 | METHODS FOR PROCESSING SUBSTRATES HAVING AN ANTIMICROBIAL COATING - Methods for processing substrate surfaces carrying coatings comprising a metal are disclosed. The methods involve providing a substrate surface having a coating comprising a metal, and exposing the substrate surface to a halogen-containing gas. | 09-09-2010 |
| 20100226907 | PURIFICATION OF BUTYRYLCHOLINESTERASE USING MEMBRANE ADSORPTION - The present invention relates to purification of butyrylcholinesterase using anion exchange material, where the butyrylcholinesterase content is enriched at least 10 fold per total protein in the composition. | 09-09-2010 |
| 20100224492 | HEMODIALYSIS AND PERITONEAL DIALYSIS SYSTEMS HAVING ELECTRODEIONIZATION CAPABILITIES - Systems and methods for hemodialysis or peritoneal dialysis having integrated electrodeionization capabilities are provided. In an embodiment, the dialysis system includes a carbon source, a urease source and an electrodeionization unit. The carbon source and urease source can be in the form of removable cartridges. | 09-09-2010 |
| 20100224329 | APPARATUS FOR STERILE CONNECTION OF TUBING - An apparatus for connecting together two sections of tubing using a laser. A pair of fixtures hold the two tubing sections in opposed, end-to-end relation so that axially facing surfaces of the tube sections at the ends are free from exposure to a surrounding environment. A photodiode laser emits an electromagnetic beam at a separate sheet of material positioned between the axial surfaces at the ends of the tubing sections. The sheet absorbs energy of the electromagnetic beam. The pair of fixtures move the two tubing sections to bring the respective axially facing surfaces of the two tubing sections into engagement with the sheet and after the axially facing surfaces of the two sections are brought into engagement with the sheet, the electromagnetic beam is directed onto the sheet for welding the two sections of tubing together. | 09-09-2010 |
